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ABSTRACT OF DISSERTATION 
 
 
THE DRUGS/VIOLENCE NEXUS: THEORY TESTING AND BEHAVIORAL 
HEALTH FACTORS AMONG JUSTICE-INVOLVED APPALACHIAN WOMEN 
 
 
This study examined the relationship between drug use and violence among justice-
involved women in Appalachian Kentucky. Goldstein’s (1985) conceptual framework 
was used as a theoretical guide in formulating the drugs and violence relationships. 
Therefore, three types of drug use and violence relationships were explored, including: 1) 
psychopharmacological violence; economic-compulsive violence; and 3) systemic 
violence. Although these drug-related violence typologies have been investigated, little 
research has been devoted to rural justice-involved women. Moreover, to date no studies 
have examined how these drug/violence relationships might be associated with 
behavioral health factors. Ergo, there were three aims of the current study. First, to build 
psychopharmacological, economic-compulsive, and systemic drug/violence predictive 
group models. Second, examine the associations between mental health symptomology 
and predicted group models. Third, examine the associations between infectious disease 
risk-factors and predicted group models. This study used secondary data from a NIDA-
funded grant focused on risk reduction among high-risk incarcerated women in 
Appalachia (N=400). All study recruitment and data collection procedures were approved 
by the university IRB. Predicted drugs/violence groups were developed using a series of 
discriminant function analyses. Predicted group models were examined for associations 
with mental health symptomology and risk factors for infectious disease using a series of 
binary logistic regression analyses. Results indicated that rural justice-involved women 
can be discriminated into distinct drugs/violence subgroups, and the 
psychopharmacological group showed the greatest prevalence. In addition, several 
behavioral health factors were uniquely associated with the psychopharmacological 
group and the economic-compulsive group. These findings could offer novel 
considerations for theory development regarding the drug-related risks for violence 
victimization among rural justice-involved women. The current research may also inform 
future traditional substance use treatment (e.g., outpatient or residential) and jail-based 
treatment (e.g., brief intervention) for rural women. Implications for theory development, 
substance use treatment and policy, future research, and the social work profession were 
discussed.  
Keywords: Drugs, Violence, Theory, Appalachia, Incarceration, Women’s Health 
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Chapter I: Introduction 
 
This section provides an outline of the purpose of the current study and an 
overview of pertinent research. A profile of the Appalachian region is provided; 
including, an overview of the predominant cultural characteristics and economic 
conditions, as well as the health disparities and social determinants of health within the 
region. A comprehensive review of substance use in Appalachia is also provided; 
including, epidemiology of substance use, differentiated patterns of substance use 
between men and women, differential patterns of substance use between urban and rural 
populations, and a brief description of Kentucky’s state drug policy efforts aimed at 
mitigating the adverse effects of the opioid crisis. The background information on 
substance use will segue to an integrated summary of violence victimization, and how it 
and substance use are an interrelated public health concern for women. To this end, 
Goldstein’s (1985) tripartite conceptual framework is introduced with support from 
relevant literature and is used to conceptually guide the summary of the drugs-violence 
victimization nexus among women. 
Statement of the Problem 
The United States (U.S.) is witnessing its most fatal drug-related crisis in its 
history as demonstrated by the fact that drug-related deaths are now the leading cause of 
unintentional death (Beletsky & Davis, 2017). Since the mid-2000s drug-related deaths in 
the US have increased precipitously, as recent reporting estimated that 72,000 died of a 
drug overdose in 2017 (Center for Disease Control and Prevention, 2018). An estimated 
10.6% of Americans (28.6 million) ages 12 years or older used any controlled substances 
in the past month (SAMHSA, 2017). That equates to about 1 in 10 individuals aged 12 or 
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older in the U.S. used illicit substances in the past month. The most commonly used illicit 
substance in the past month was marijuana (24 million). About 6.2 million people 
reported using psychotherapeutic drugs, and among them, 3.3 million people were 
misusers of prescription pain medication. In other words, among specific illicit drugs, 
prescription pain medication was the second highest used substance behind marijuana 
(SAMHSA, 2017). Past 12 months prevalence rates (in millions) for the remaining illicit 
substances is as follows: misuse of prescription tranquilizers (2.0); cocaine (1.9); misuse 
of prescription stimulants (1.7); hallucinogens (1.4); methamphetamine (0.7); inhalants 
(0.6); misuse of prescription sedatives (0.5); and heroin (0.5). 
To better understand the current drug-related public health crisis, it is important to 
contextualize how opioid prescription practices have changed over the recent decades. At 
the national level, the assessment and treatment of chronic non-cancer pain underwent 
major changes with the issuance of new practice standards of care. For example, in 1998, 
the Veterans Health Administration (VHA) implemented an initiative called “Pain as the 
5th Vital Sign,” which was strategically designed to improve the quality of patients’ pain 
treatment (Tompkins, Hobelmann, & Compton, 2017).  
This initiative expanded primary care physician’s opioid prescribing capacity. 
Prior to these changes, prescription opioids were typically only considered for the 
treatment of severe pain (Hwang, Chang, & Alexander, 2015;Van Zee, 2009). 
Concurrently, pharmaceutical manufacturers promoted off-label application of opioids to 
ailments that were not traditionally thought of as being treated by this class of medication 
(Chou et al., 2015). Taken together, the increasing rate of prescribing opioid analgesics 
may have resulted in the high prevalence of prescription opioid misuse and mortality. To 
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reign in liberal prescribing practices, most states enacted medical surveillance laws that 
aimed to monitor prescribing patters to reduce the illicit use of prescription opioids. 
Although well intended, these policy actions have led researchers to suggest that 
individuals have been forced to more dangerous opioid analogs (e.g., heroin and 
fentanyl), resulting in increases in opioid-related mortality (Beletsky & Davis, 2017; 
CDC, 2018). 
The Office of National Drug Control Policy’s (ONDCP) recently expanded its 
strategy for reducing opioid misuse (Brady, McCauley, & Back, 2015). The ONDCP 
initiatives have largely targeted education to patients and providers (e.g., informing the 
dangers of misuse), and policy reform (e.g., Prescription Drug Monitoring Programs). 
Apart from federal policies, state and local governments have also enacted policies to 
reduce opioid misuse, with varied objectives and approaches (Dasgupta et al., 2014; 
Cicero et al., 2014). For instance, policy measures have attempted to address this problem 
in many ways by reducing supply, by monitoring use and potential misuse, by reversing 
overdoses, by increasing access to treatment and prevention, and by humanizing the 
epidemic (Koh, 2015).  
At the forefront of enforcement efforts are Prescription Drug Monitoring 
Programs (PMDPs), which electronically tracked prescriptions of all controlled drugs. 
Prescription Drug Monitoring Programs currently operate in 49 states except Missouri 
and Washington, DC (Koh, 2015). Although nearly all states have PDMPs, most do not 
have legislation that mandates utilization; thus, many states have utilization rates at or 
below 50%. As of July 2013, 16 states (Colorado, Delaware, Kentucky, Louisiana, 
Massachusetts, Minnesota, Nevada, New Mexico, New York, North Carolina, Ohio, 
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Oklahoma, Rhode Island, Tennessee, Vermont, and West Virginia) had legislation 
mandating prescribers, and in some cases, dispensers use their respective PDMP 
(Haffajee, Jena, & Weiner, 2015). Yet, the mentioned legislative mandates differ in the 
conditions under which they must be operated. For example, the Oklahoma statute (2010) 
requires checking PDMP only when prescribing methadone (Prescription Monitoring 
Programs Center of Excellence, 2014). On the contrary, Kentucky’s PDMP mandates 
have wider conditions of application, including all scheduled drugs—perhaps because 
Kentucky ranks among the highest prescribers of opioid medication (Keyes, Cerdá, 
Brady, Havens, & Galea, 2014). 
In general, women represent a population-group that displays an increasing 
prevalence rates of substance misuse (SAMHSA, 2017). Compared to men, women more 
often present with more significant comorbid conditions, such as mood and anxiety 
disorders (Moon, 2017). According to SAMHSA (2017), gender has been found to 
predict differences in how men and women administered and were impacted by substance 
use. For instance, women have been found to use substances differently (e.g., increased 
injection drug use among young women). In addition, women have been found to have 
different acute and chronic effects of substance use (e.g., endocrinology, dosage, etc.), to 
be more likely to overdose or die from substance use, and to be more likely to use 
substances if they are victims of domestic violence (Evans et al., 2015; SAMHSA, 2017).  
Gender differences also have been found when investigating the typology of 
violent acts (e.g., perpetrator of violence and/or victim of violence) in association to 
substance misuse. Past research supports the notion that women are significantly more 
likely to be victimized by violent acts than men (Goldstein, 1998; Goldstein, 1985). 
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Empirical evidence has also demonstrated that violent perpetrators and victims of 
violence have similar characteristics, insofar that they are both vulnerable to violent 
behavior (Goldstein, 1985). For instance, an individual using substances may be 
vulnerable to victimization because of impairment due to his or her use (e.g., 
psychopharmacological violence), due to economic crimes committed to support drug use 
(e.g., economic-compulsive violence), and individuals working in illicit markets are 
vulnerable because they often carry large sums of money or drugs (e.g., systemic 
violence) (Oser, Money, Staton-Tindall, & Leukefeld, 2009; Weiner, Sussman, Sun, & 
Dent, 2005). Therefore, individuals who use drugs – independent of gender – may be 
perpetrators or victims of violent behavior for reasons related to the 
psychopharmacological, the economic compulsive, or the systemic contexts of drug use 
(Boles & Miotto, 2003; Goldstein, 1985; Goldstein, 1998; MacCoun, Kilmer, & Reuter, 
2003). 
The majority of research to date on substance use and violence has neglected to 
consider varied contextual and demographic factors that distinguish rural residents from 
urban- or national-samples. Justice-involved individuals are a vulnerable population 
group that typically have higher incidents of substance use prevalence as well as higher 
occurrences of violence, compared to the general population (Glaze & Herberman, 2011). 
Moreover, justice-involved women from the economically distressed region of 
Appalachia represent a unique subpopulation relative to generalized justice-involved 
samples (Staton-Tindall et al., 2015). Specifically, the central Appalachian region is one 
in which substance using women have significant barriers to treatment (Staton-Tindall, 
Duvall, Leukefeld, & Oser, 2007; Victor, Kheibari, Staton, Oser, 2017) and the region 
6 
 
has been disproportionately impacted by the prescription opioid crisis (Victor, Walker, 
Cole, & Logan, 2017; Slavova et al., 2017).  
Perspective of Appalachia 
The Appalachian region is defined as a 205,000-square-mile region that is 
connected by the Appalachian Mountains, which span from southern New York to 
northern Mississippi (Appalachian Regional Commission [ARC], 2017). This region 
includes all of West Virginia and portions of 12 other states, including: Alabama, 
Georgia, Kentucky, Maryland, Mississippi, New York, North Carolina, Ohio, 
Pennsylvania, South Carolina, Tennessee, and Virginia. Appalachia is further divided 
into three sub-regions, which include the north, central, and southern regions.. 
Appalachia was defined as a distinct region primarily due to the nation’s interest in 
addressing the social welfare needs of the inhabitants of the region. Generally, the 
Appalachian region has been marked by endemic poverty, limited economic growth, poor 
housing, greater health disparities compared to the general population, and limited 
transportation and medical facilities (ARC, 2017). This study primarily focuses on the 
eastern Kentucky counties that form the central Appalachian sub-region (ARC, 2017). 
Racial minorities make up a marginal percentage of Appalachia’s population 
(18.2%), but this number has increased by 16.2% since 2010 (ARC, 2017). Among 
Appalachia’s minority populations, African Americans are the largest group (9.7%); 
followed by Hispanics/Latinos (4.9%). The median age in Appalachia (40.9 years) is 
higher than the national average (38.0 years). Education attainment falls behind national 
averages in Appalachia; among Appalachian adults, 85.9% (U.S. 87.0%) have earned a 
high school diploma, and 23.2% (U.S. 30.3%) have earned a bachelor’s degree (ARC, 
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2017). Compared to the greater Appalachian region, Kentucky’s Appalachia has the 
lowest education attainment of a bachelor’s degree at 13.6% (ARC, 2017). 
Appalachia’s household income in 80% of the U.S. average ($62,299 vs 77,866), 
and Appalachia’s poverty rate is higher than the U.S. average (16.7% vs 15.1%). Within 
Appalachia, household income is lowest in central Appalachia (i.e., $48,706). Although 
much of the Appalachian region has experienced outmigration, the southern Appalachia 
has witnessed population growth of 4.7% from 2012 to 2016 (ARC, 2017). In 
Appalachian Kentucky, 37 of the 54 counties are considered economically distressed, 
with pockets of distress and at-risk counties throughout the region; thus, making this one 
of the most underserved economic regions in the entire U.S. (ARC, 2017).  
Women residents living in Appalachian Kentucky have contrasting 
socioeconomic factors compared to men. For instance, Fiene (2002) notes that 
Appalachian women of low socioeconomic status may have their opportunities for 
educational and professional attainment curtailed by traditional gender roles within the 
family and community. Gender roles and patriarchal formalities are not the only factor 
that may impede central Appalachian women’s socioeconomic standing, as much of the 
labor force in the region is dominated by male-oriented jobs (e.g., coal mining) (Miewald 
& McCann, 2004). Although recent evidence suggests that employment in the extraction 
industries are waning in favor of careers that require more education, progress has been 
gradual, and the central Appalachian region still compares unfavorably to other regions 
(ARC, 2017).  
Appalachian women living in Kentucky have the highest high school drop-out 
rate compared to all Appalachian regions (i.e., 24.0%) and to the U.S. national rate (i.e., 
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14.2%) (Haaga, 2004). In addition, women in Kentucky’s Appalachia rank lowest in 
terms of post-secondary degree attainment (Brinley et al., 2018; Ferris, 2017). The 
inequalities in occupation, income and status – all social determinants of health – faced 
by Kentucky’s Appalachian women have been linked with a predisposition of poorer 
health and quality of life (Marmot & Allen, 2014). Furthermore, considering the 
intersectionality of social class and gender, the inequalities among Kentucky’s 
Appalachian women – including inequalities within Appalachian women – may 
predispose the most underserved populations to negative coping strategies, such as 
substance misuse, and put them at-risk for victimization. 
Economic Distress in Appalachia 
The Kentuckian Appalachian region is one of the most economically distressed 
regions in the nation (ARC, 2017). The ARC uses a socioeconomic classification system 
that compares three-year averages of central Appalachian counties with the national 
averages, based on measures of unemployment rates, per capita income, and poverty rates 
(ARC, 2017). Against that backdrop, the region has witnessed improvements in poverty 
rates – 31% in 1960 to 17.1% in 2015 – and the number of “high-poverty” counties (i.e., 
counties with poverty rates more than 1.5 the U.S. average) has declined from 295 in 
1960 to 87 in 2015 (ARC, 2017). Several Kentucky Appalachian communities have 
developed multifaceted economies, yet others still lack basic infrastructure, such as water 
and sewage systems (ARC, 2017). This region has the largest number of counties that 
rank in the lowest 10% in terms of socioeconomic status (Pollard & Jacobsen, 2015). In 
addition, the region has the most rural counties, as compared to other Appalachian sub-
regions, and the least number of inhabitants per square mile than the other sub-regions 
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(ARC, 2017). The rural and isolated nature of Kentucky’s Appalachia have implications 
for health disparities in the region. These health disparities are accentuated by limited 
access to specialized healthcare services and an overall lack of a community-level 
continuity of care (Halverson, Friedell, Cantrell, & Behringer, 2012).  
Health Disparities in Appalachia 
Many challenges persist despite the gradual economic progress made in select 
areas of the Appalachian regions. Overall, the health disparities in Appalachia are greater 
than those of the general U.S. population. Among the top ten leading causes of death in 
the U.S., the Appalachian region has higher mortality rates for 7 of the 10 – heart disease, 
cancer, chronic obtrusive pulmonary disease (COPD), injury, stroke, diabetes, and 
suicide. Mortality due to poisoning, which includes drug overdose, is higher by a distinct 
margin when compared to the general U.S. population (ARC, 2017; Borak et al., 2012). 
Compared to the general U.S. population, Appalachian non-fatal health outcomes are 
worse across several health domains, including, the number of physically unhealthy days, 
the number of mentally unhealthy days and the prevalence rates of depression (ARC, 
2017; Borak et al., 2012). In addition, risk factors that are associated with a host of health 
problems are also higher in Appalachia; these include, obesity, smoking and physical 
inactivity (ARC, 2017; Borak et al., 2012). Social determinates of health also play a role, 
as low household incomes and high poverty rates reflect poor living conditions compared 
to the general U.S. (ARC, 2017; Borak et al., 2012).  
Drug overdoses and other forms of mortality due to poisoning are 37% higher in 
Appalachia than in the general U.S. population. Behavioral health is also a concern, as 
Major Depressive Disorder (MDD) in Appalachia is 16.7% higher than the national rate, 
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and suicide rates are 17.0% higher than the national rate (ARC, 2017). In addition, 
individuals living within Appalachian Region’s rural counties are 21 percent more likely 
to commit suicide than those living in the Region’s large metro counties, and the 
poisoning mortality rate is 40 percent higher in the Region’s rural counties than in its 
large metro counties (ARC, 2017). Among all behavioral health indicators, 46% of 
Appalachian counties are in the worst-performing national quintile for poisoning 
mortality (ARC, 2017). 
Individuals residing Appalachia demonstrate numerous needs and barriers to care, 
including: 1) poverty and unemployment rates well above state and national averages; 2) 
incarceration rates above the national average; 3) significant problems in accessing 
affordable health care; 4) fewer health care providers per captia when compared to 
national averages; 5) substance misuse and mortality rates well above national averages; 
and 6) individual and community health indicators that are ranked nationally near the 
bottom in most health-related metrics (e.g., chronic disease, substance abuse and 
addiction, heart disease, diabetes, etc.). More recently, Kentucky ranks in the top five 
among states that have been impacted by the opioid crisis. According to the Kentucky 
Injury and Prevention and Research Center (KIPRC) approximately 30 out of every 
100,000 people have died of a drug overdose in Kentucky from 2011 to 2014. 
Drug Use-Related Health Disparities 
The risk of contracting a chronic disease, such as HIV/AIDS or Hepatitis C, 
increases significantly among individuals with a substance use disorder (SUD), among 
injection drug users (IDU) and among individuals who experience a discontinuity of 
health care (Perazzo, Reyes, & Webel, 2017). Much of the Appalachian region is 
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considered by the CDC to be high-risk for HIV and HCV infections due to IDU (Van 
Handel et al., 2016). Of note, Appalachian Kentucky was identified as having 8 of the top 
10 at-risk counties, among the 220 nation-wide counties listed by the CDC (Van Handel 
et al., 2016).  
Among those engaging in IDU, research links low health literacy to the 
contraction of a chronic disease or life-threatening infection, and there is evidence to 
suggest health education mitigates this risk (Perazzo et al., 2017). That is, individuals 
have been found to be unaware of the potential health risks that are associated with their 
substance use (e.g., sharing syringes), although they may be aware of more direct health 
risks (e.g., overdose). In addition, being introduced to injection behavior by a male 
intimate partner has been found to increase high-risk injection (Morris et al., 2014). Most 
experts agree that prevention, education, and harm reduction strategies are some of the 
best tools to combating the potentially lethal effects of the current opioid crisis (Kolodny 
et al., 2015).  
Health and Social Factors for Justice-Involved Women 
Women have been disproportionately affected by the policies and practices that 
have contributed to mass incarceration (Alexander, 2012). Since 1980, the rate of 
incarcerated women has increased by 336%; during the same period, men’s incarceration 
rate has increased by 189% (Belenko, 2006). In terms of treatment needs, there are 
generalities that can be made between justice-involved men and women. However, the 
etiology and severity of treatment needs requires a gender-focused perspective. These 
disparities are particularly pronounced for mental and physical health, vocational training 
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and employment, familial issues, child care, and HIV and other infectious disease 
(Belenko, 2006).  
Recent major welfare reform – the Federal Personal Responsibility Act of 1996 
(PRWORA) – has arguably increased the burden of employment for women. This 
legislation, which includes Temporary Assistance for Needy Families (TANF), 
established limits on the length of time that an individual is eligible to receive welfare 
benefits, it requires employment in some cases, and denies benefits to felons with 
substance use histories (Belenko, 2006). This is problematic for many justice-involved 
women with substance use issues, because employment is a meaningful component of 
recovery, and because women who use substances are more likely to have more extensive 
trauma histories that significantly influence offending behavior, and as an extension, 
negatively influence their employment opportunities (Moloney, van den Bergh, & 
Moller, 2009). In addition, parenting responsibilities commonly are placed on women, 
which may limit women’s ability to attend post-release treatment and attain additional 
resources (Moloney et al., 2009).  
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Chapter II: Review of Relevant Literature 
Substance Use Epidemiology in Appalachia 
Compared to urban settings, rural areas have greater prevalence rates of substance 
use among several substances, such as prescription opioids (Small, Curran, & Booth, 
2010; Shannon, Havens, & Hays, 2010; Jackson & Shannon, 2012). Kentucky, and other 
states with large rural populations (e.g., Kentucky, West Virginia, Tennessee) have 
witnessed higher concentrations of prescription opioid morbidity, mortality, and 
infectious disease in recent years (Keyes et al., 2014; Zibbell et al., 2015). Paulozzi and 
Xi (2008) note that rural area non-medical use of prescription opioids (NMUPO) has 
increased at a rate greater than three-fold when contrasted to metropolitan counties. 
Along with the high prevalence of substance use, rural areas also have unique challenges 
to providing recovery services. For example, rural communities are more likely to have 
limited health service providers, and if recovery services are available, utilization of 
services can be complicated by client transportation challenges (Victor et al., 2017; 
Beardsley, Wish, Fitzelle, O’Grady, & Arria, 2003; Pullen & Oser, 2014).  
Along with the unique challenges of providing substance use treatment in rural 
communities, there are also regional (e.g., rural southeast) and demographic (e.g., 
vulnerable populations) differences in the prevalence of substance use disorders (SUD) 
and the need for services (Oser et al., 2016; Varga & Surratt, 2014; Shannon, Havens, 
Mateyoke-Scrivner, & Walker, 2009). For instance, NMUPO is more prevalent in the 
southeastern rural areas of the U.S., and rural areas have also beheld a pronounced 
increase in injection drug use (IDU) in recent years (Reifler et al., 2012; Staton-Tindall et 
al., 2015b). Havens and colleagues (2006) found that the high rate of opioid prescriptions 
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in rural Kentucky was correlated with regions that were classified as economically 
distressed, which was operationally defined as poverty, fewer local treatment resources, 
and higher rates of disability.  
In rural Kentucky communities, substance use remains a growing public health 
concern, with specific emphasis placed on NMUPO, heroin, and co-occurring IDU and 
infectious disease (Keyes et al., 2014; Staton-Tindall et al., 2015b; Havens et al., 2011). 
This region ranks among the highest in the country for rates of prescription drug misuse, 
and rural residents have been found to be significantly more likely to misuse prescription 
drugs as compared to urban residents (Young, Havens, & Leukefeld, 2010). In recent 
years, the rise in IDU in the Appalachian region has elevated the public health risk. In 
Kentucky, by 2002 approximately 16% of self-reported drug users indicated having ever 
injected any drug (Christian, Hopenhayn, Christian, McIntosh, & Koch, 2010; Young & 
Havens, 2012). Injection prevalence rates (44.3%) in Appalachian Kentucky have 
increased considerably since the mid-2000’s and are higher among samples of opioid 
users (Havens et al., 2007; Staton-Tindall et al., 2015b).  
Patterns of Substance Use Among Women 
The past three-decades of addiction research has revealed gender differences in 
the health consequences of drug use, in the physiological responses to drug use, clinical 
correlates of drug use, and in the patterns of both the administration of drugs and the 
general use (Ashenberg-Staussner & Brown, 2002; Tuchman, 2010). Gender differences 
have been reported in the types of substances used and patterns of drug use over one’s 
lifespan (SAMHSA, 2017). National survey data (SAMHSA, 2017) shows that illicit 
drug use (e.g., marijuana, cocaine, psychotherapeutics) among individuals over the age of 
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12 was more common among men (11.5%) compared with women (7.3%) and that men 
were more likely to report alcohol use (57.1%) than women (47.5%). 
Gender differences emerge when investigating the patterns of illicit and licit 
substance use. Generally, women begin self-administering licit and illicit substances at 
lower doses compared to men. However, women’s use generally escalates to dependence 
more quickly, as compared to men. In addition, gender disparities in substance use 
prevalence is demonstrated by the striking data regarding prescription opioid use among 
women. That is, there has been a 400% increase in deaths related to prescription opioid 
overdoses, relative to the 265% increase in deaths among men; although, men continue to 
have higher rate of prescription opioid deaths (Dart et al., 2015). Given the rise in 
NMUPO in the past decade, researchers have begun to identify trajectories of drug use. 
Back and colleagues’ (2011) describe the accelerated progression of OUD among 
women by focusing on several biopsychosocial elements. These gender differences in 
physiology (i.e., metabolic rate, gastric dehydrogenase, hormonal fluctuations) and in 
society (i.e., adverse social consequences) can place women at increased risk of 
experiencing negative health consequences as a result of their OUD (Greenfield, Back, 
Lawson, & Brady, 2010). The empirical findings of gender-specific correlates of 
NMUPO are consistent with previous research concerning other drugs of misuse 
(Tuchman, 2010), as women appear to have different reasons for engaging in drug use, 
accelerated progression of addiction, and complex health and mental health-related 
concerns (McHuegh et al., 2013).  
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Patters of Substance Use among Rural Appalachian Women 
One population group that is affected at a greater proportion by the mentioned 
rural drug trends are women; more specifically, economically disadvantaged rural women 
(Staton-Tindall et al., 2015a; Staton-Tindall et al., 2015b; Browne et al., 2016; 
Appalachian Regional Commission, 2017). Many of these women have been incarcerated 
for drug offenses, particularly as sentencing has changed (Mumola and Karberg 2006). 
Though initially public health advocates drew attention to the adverse health effects of 
incarceration itself (Massoglia 2008), more recent research has stressed the health risks 
that may occur upon reentry (Cook et al. 2005; Fogel et al. 2014). 
Conditions related to economic distress increases the likelihood that individuals 
from Kentucky’s Appalachian region will have low social capital, greater health 
disparities, and limited environmental resources (Marmot & Bell, 2009). For drug-using 
women in central Appalachian Kentucky, the economic and substance misuse problems 
in the region are compounded by co-occurring mental and physical health concerns, low 
health literacy regarding drug misuse, and the scarcity of treatment centers and/or 
resources (Snell-Rood, Staton-Tindall, & Victor, 2015; Havens et al., 2006). Moreover, 
these social determinates of health increase the likelihood of numerous health issues; 
including among others, substance misuse and co-occurring related health issues (Varga 
& Surratt, 2014; Webster et al., 2006).  
Background on Substance Use and Violence 
The relationship between substance use and violence has been given considerable 
empirical attention. Current research has been primarily suggestive rather than conclusive 
(Goldstein, 1998; Weiner, Sussman, Sun, & Dent, 2005).  Evidence suggests that those 
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who use alcohol and drugs are commonly non-violent (Fagan, 1990); although, there is 
empirical support to suggest alcohol use, and to a lesser degree substance use, has been 
found to be present in both offenders and victims of violent acts. Substance use occurs in 
a myriad of conditions; including, the environmental, the social, and the cultural contexts 
that influence the potential for exposure to violence (Weiner et al., 2005). Certain 
substances have been linked with a greater likelihood of violence; such as, alcohol and 
illicit stimulants (e.g., amphetamines and cocaine) (Boles & Miotto, 2003; Goldstein, 
1998; Goldstein, 1985; Oser et al., 2009). Furthermore, violence has been found to occur 
in various phases of drug use, including acute intoxication, acquiring or distributing 
drugs, and during episodes of drug induced psychosis and paranoia (Boles & Miotto, 
2003; Goldstein, 1998). 
It is also important to consider neurobiological factors involved in violence, 
although there is no evidence to date that suggests these factors cause violence (Boles & 
Miotto, 2003). The current understanding of how neurobiology is associated with 
aggression is centered on monoamine neurotransmitters (i.e., serotonin, dopamine and 
norepinephrine). That is, researchers believe that alterations in these neurotransmitters are 
correlated with violent behavior. Broadly stated, these neurotransmitters are involved in 
behavioral regulation. Abnormal serotonergic activity has been correlated to 
psychological disorders and aggression (Kyes, Botchin, Kaplan, Manuck, & Mann, 
1995), as well as being predictive of impulsive behavior, depression, and anxiety 
(Robbins & Dailey, 2017; Higley & Linnoila, 1997).  
Acute alcohol consumption causes a release of serotonin, and among a subset of 
individuals with alcohol use disorder, baseline serotonin activity is lower compared to 
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control groups (Higley & Linnoila, 1997). Therefore, the association between alcohol and 
violence may be mediated by the neuroactivity of serotonin (Duke, Bègue, Bell, & 
Eisenlohr-Moul, 2013). Dopamine and norepinephrine have been linked to reward cues 
(e.g. environmental triggers) and multiple behavioral processes; such as, attention, 
arousal and vigilance (Duke et al., 2013).  
Endocrinological interactions have also been found to possibly play a role in 
aggressive behavior (Boles & Miotto, 2003). Elevated levels of the sex hormone 
testosterone have been correlated with violent behavior. In studies comparing violent and 
nonviolent participants, among an array of study samples, those with higher blood 
testosterone levels were consistently in the violent group (Brooks & Reddon, 1996). 
More generally, “top-down” control systems in the prefrontal cortex fail to modulate 
aggressive behavior when there is insufficient serotonergic facilitation (Siever, 2008). 
The hypothalamus-pituitary-adrenal (HPA) axis also plays a key role in both substance 
use behaviors and violent aggression, and these systems are influenced by regulatory 
action found in the prefrontal cortex. Such that, a hyper-responsive arousal system, 
including the amygdala, can affect evaluations of threat while also drive compulsory 
substance use (Siever, 2008).   
Theoretical Perspective: Goldstein’s Tripartite Conceptual Framework 
In 1985, Goldstein first published his tripartite conceptual framework (Table 1), 
which posited three pathways by which the use of controlled substances may influence 
interactions with violence: 1) psychopharmacological pathways; 2) economic-compulsive 
pathways; and 3) systemic pathways. The psychopharmacological pathway theorizes that 
the altered psychological and physical effects of drug use lead to agitation, aggression, 
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impulsivity, and cognitive impairment, increase the risk for violent behavior; along with 
impairing decision-making and communication skills needed to avoid violence. The 
economic compulsive pathway theorizes that obtaining illicit substances often entails an 
individual to produce the capital to make a purchase; therefore, during a robbery or a 
similar incident, violence may be used as a mean expedite the process, or for the purposes 
of risk-aversion on part of the perpetrator. The systemic pathway theorizes that disputes 
within illegal markets, such as the drug trade, can lead to violence to resolve conflicts 
over “turf”, and/or for coercion and power.  
Drug/Violence Relationship Definition 
Psychopharmacological 
Physical and psychological effects of 
controlled substances on violence 
 
Economic-compulsive 
Violence as the means for financing illicit 
drug use (e.g., assault during a robbery) 
 
Systemic 
Violence emerging from disputes within 
illegal markets/informal economies (e.g., 
drug dealing or sex work in exchange for 
drugs) 
Goldstein (1985) 
Figure 1: Goldstein’s tripartite conceptual framework. 
 
 
Literature applying the Goldstein (1985) framework has identified that urban men 
and women contrast in their experiences of violence in association to their substance use. 
Goldstein et al. (1988) initial study of his conceptual framework was conducted in New 
York City amid the crack cocaine epidemic. In this seminal study, Goldstein et al. (1988) 
worked alongside law enforcement to identify 218 drug-related homicides. In this 
sample, 17% were classified as psychopharmacological, 4% were classified as economic 
compulsive, and 75% were classified as systemic, while 7% were considered 
“multidimensional.”  
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Among urban samples, men have been found to have a greater likelihood to 
perpetrate violence when under the influence of greater volumes of drugs (Goldstein, 
Brownstein, & Ryan, 1988; Goldstein, Brownstein, Ryan, 1992; Weiner et al., 2005). 
However, under similar conditions, women have been found to be at a greater risk for 
victimization of violence in association to their drug use (Oser et al., 2009). To date, 
there has been limited application of Goldstein’s (1985) framework on rural incarcerated 
women; in addition, it is unclear how rural incarcerated women’s substance use and 
violence would be situated within this framework, and to what extent this framework is 
associated with infectious disease and mental health among incarcerated women.  
In addition to Goldstein’s (1985) conceptual framework, over the past three 
decades feminism scholarship has developed a strong body of literature that has informed 
the modern understanding of women’s configuration within the criminal justice system 
(Chesney-Lind, 2006; Renzetti & Goodstein, 2000). Feminist criminology was developed 
across the late 1960s to early 1970s, as a response to the general lack of diversity and 
discrimination in the study of criminal justice research and the fundamental features of 
the “backlash political agenda” – racism and sexism (Chesney-Lind, 2006). 
In response, feminist criminologists centered the foci of their scholarship and 
research on race/gender/punishment nexus. This meant advocating against the oppressive 
and racist nature of the criminal justice system and its disproportionately punitive nature, 
especially with respect to African American women (Chesney-Lind, 2006). Moreover, 
feminist criminologists challenged the mischaracterization(s) of women in criminal 
justice theory and research. These efforts in advocacy and scholarship have brought forth 
meaningful social change and advancement of policy. Women’s victimization, 
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particularly domestic violence, began to be defined and criminalized after an extended 
period of neglect due to the androcentric authority over the discourse within the criminal 
justice system (Chesney-Lind, 2006).  
Feminist criminologists argue that one of the most comprehensive case studies in 
the race/gender/punishment nexus is the “war on drugs.” This called for an increase 
attention to the documentation and discussion of women in crime, with less emphasis on 
“victimology,” and more so on the gender-specific pathways to criminal involvement 
(Chesney-Lind, 2006). Formative scholarship and research followed that began to 
identify how violent victimization shaped women’s drug use and criminal behavior, 
especially in underserved communities (Burkhart, 1976; Chesney-Lind & Rodriquez, 
1983; Chesney-Lind & Shelden, 2013; Gilfus, 1993). And the attention is surely still 
relevant to the race/gender/punishment nexus. Current feminist advocacy and 
scholarship, such as the #MeToo movement, has begun to develop a literature base with 
themes relevant to gender-based violence and justice (Wexler & Robbennolt, 2019).  
Psychopharmacologic Violence among Women in Community Populations 
McCoy et al. (2001) analyzed how an individual’s experience in ever observing 
violence, perpetrating violence, or victimized by violence based on their drug use status 
(i.e., chronic drug users (CDUs) versus non-chronic drug users (NCDUs)). This study 
used a snowball sample that was comprised of community members in Miami, Florida. 
For their analyses, the authors used chi-square tests and logistic regression models. They 
found that among CDUs and NCDUs, women were significantly less likely to be 
observers (p < .001) and perpetrators (p < .001). Gender was also a significant predictor 
in the regression models. Compared to women, men were significantly more likely to 
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observe someone beaten (OR = 3.07; CI = 2.26-4.14, p < .001), shot (OR = 2.28; CI = 
1.81-2.87, p < .001), robbed (OR = 2.77; CI = 2.18-3.53, p < .001), or killed (OR = 2.17; 
CI = 1.72-2.74, p < .001). Men were also significantly more likely to perpetrate a beating 
(OR = 3.25; CI = 2.54-4.16, p < .001), a shooting (OR = 1.68; CI = 1.22-2.31, p < .01), a 
robbery (OR = 2.13; CI = 1.56-2.91, p < .001), or a rape (OR = 5.56; CI = 1.19-25.64, p < 
.05); however, women were significantly more likely to be victims of rape (OR = 0.06; 
CI = 0.04-0.09, p < .001).  
Overall, the regression models suggested that female CDUs were at greater risk 
for violence victimization compared to female NCDUs. Of note, female CDUs and 
NCDUs were both found to be at greater risk for violent victimization compared to men 
(p < .01). The findings in this article suggest that drug use severity is a major factor in the 
incidents of violence one is exposed to, as well as a strong predictor of different types of 
violent acts. However, the authors stressed that the linkages found in this study between 
drug use and violence are more indicative of a network interacting processes, rather than 
causal processes.  
Busch-Armendariz et al. (2010) compared victims' sexual assault experiences 
based on whether the perpetrators were or were not using alcohol or drugs during a 
sexual assault. This study used a statewide survey sample of Texas residents via the 
Health Survey of Texans: A Focus on Sexual Assault. The analyses conducted included 
descriptive tests, cluster analysis, and logistic regression models. The outcome variables 
included variables of violence (i.e., slapping, hitting, kicking, biting) that occurred 
concurrently with sexual assault, and variables of events (i.e., how many days a 
participant had to take time off work, school, home, or recreational time). The 
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independent variables included the alcohol and/or drug use by victim at the time of the 
assault, alcohol and/or drug use by perpetrator at the time of the assault, race/ethnicity, 
and the victims’ relationship to the perpetrator.  
Findings relevant to the perpetrators’ alcohol and/or drug use indicated that 38.8% 
used at the time of the assault. Moreover, victims’ alcohol and/or drug use at the time of 
the assault was reported at 13.0%. The logistic regression results indicated that for 
concurrent assault outcomes, the use of alcohol and/or drugs by the perpetrator 
significantly increased the likelihood of intercourse or penetration (OR = 3.99, p = .002), 
violence (OR = 3.92, p = .021), threat to harm or kill (OR = 3.14, p = .016), and physical 
injury (OR = 2.64, p = .038). In terms of the post-assault outcomes, the perpetrators’ use 
of alcohol and/or drugs significantly increased the likelihood of the victim taking 
recreation time off (OR = 4.17, p = .004) and at least one day off recreation (OR = 3.27, p 
=.016). The findings from this article suggest that a perpetrators’ use of alcohol or drugs 
at the time of a sexual assault places the victim at a greater likelihood for further physical 
injury, and a loss of time from a multitude of life events. Also, the impact of the 
psychopharmacological pathway is highlighted in this study given that the relationship to 
the perpetrator, the location of the sexual assault and the race/ethnicity of the victims did 
not affect the findings.  
Afifi et al. (2012) examined the relationship between perpetration and 
victimization of physical and sexual IPV, and substance use disorders (SUDs) in the past 
year by using national-level epidemiological survey data. The sample was stratified by 
sex and used a four adjusted logistic regression models. The substances that were 
significantly associated with victimization of IPV, included alcohol (AOR = 0.33; CI = 
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0.24-0.44), cocaine (AOR = 0.28; CI = 0.10-0.80) and cannabis (AOR = 0.49; CI = 0.29-
0.81). These results indicate that women with alcohol, sedative/tranquilizer, cocaine, and 
cannabis SUD in the past year were significantly less likely to perpetrate IPV compared 
to men with the same SUDs in the past year. Female victims of IPV were also 
significantly less likely to have alcohol, cocaine, and cannabis SUD in the past year 
compared to male victims of IPV.  
Kramer et al (2012) examined how drug use affected physical victimization 
among a sample of rural residents in Arkansas, Kentucky and Ohio. A series of logistic 
regression models found that several factors significantly increased women’s' risk of 
violence victimization in the past year. For instance, compared to women over 41 years 
old, women aged 23 to 41 were significantly more likely (OR = 3.88; CI = 1.18-12.71) to 
experience IPV. Substance use also significantly identified risk for women; such that, 
alcohol misuse/dependence (OR = 3.76; CI = 1.59-8.88), cocaine abuse/dependence (OR 
= 3.09; CI = 1.15-8.30), methamphetamine abuse/dependence (OR = 2.93; CI = 1.06-
8.06), and the number of drugs used (OR = 0.74; CI = 0.60-0.92) increased the likelihood 
of being a victim of IPV among this sample of rural women.  
Lee et al (2010) examined the association of both perpetrators' and victims' 
substance use with victim outcomes. The researchers utilized a snowball sampling 
technique to recruit 114 battered women to conduct phone interviews in the following 
metropolitan areas: 1) Pittsburgh (35%); 2) San Jose (28%); 3) Dallas (19%); and 4) 
Minneapolis/St. Paul (18%). The two outcome measures were defined as, victims' 
physical injury, and victims' functional impairment following the violent incident.  
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Substance use by both perpetrators and victims was not significantly associated to 
increased risk of victims' physical injuries. However, Lee and colleagues (2010) did find 
a significant association between victims' substance use and their functionality following 
an IPV incident. That is, compared to those who reported no substance use by perpetrator 
or victim, the group where substance use by a perpetrator and victim was entered, R2 was 
significantly increased from .32 to .40 (p < .05). Meaning, this finding suggests that when 
perpetrators and victims both are involved in substance use at the time of a violent 
incident, the victim is more likely to have greater functional impairment versus a control 
group. 
Psychopharmacologic Violence among Women in Substance Use Treatment 
Schumm et al (2011) tested a conceptual model that integrates individual and 
relationship pathways of IPV, to examine the IPV risk factors among a sample of 277 
women entering substance abuse treatment. To qualify women must have had a 
relationship with a male partner. Participants were questioned about their partners across 
four domains, and these domains also functioned as the independent variables for this 
article, they included: 1) antisociality/generalized violence; 2) heavy alcohol or drug use; 
3) relationship adjustment; and 4) psychological and physical IPV. The primary outcome 
variables were physical and psychological IPV by gender. A structural equation model 
(SEM) was used to test pathways from latent predictor variables to the outcome variables 
(i.e., IPV). Results revealed several statistically significant pathways of IPV.  
Partner's antisociality/generalized violence showed a direct positive association 
with her or his own perpetration of IPV (Female psychological IVP = R2 = .25, p < .001; 
Female physical IPV = R2 = .29, p < .001; Male psychological IPV = R2 = .21, p < .001; 
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Male physical IPV = R2 = .25, p < .001). A negative association was found between both 
partners' relationship adjustment and psychological IPV (Female psychological IPV = R2 
= -.24, p < .001; Male psychological IPV = R2 = -.23, p < .001). The findings regarding 
substance use and IPV were mixed. A positive relationship was found between female 
drug use and female physical IPV (R2 = .18, p < .001), yet male heavy drinking had a 
positive association with male psychological IPV (R2 = .12, p < .05).  
Additional tests were conducted to examine indirect pathways to IPV. Female 
heavy drinking is shown to exhibit a positive indirect effect on female psychological IPV 
via relationship functioning (standardized indirect effect = .04, p < .01). Female heavy 
drinking also exhibited a positive indirect effect on female physical IPV via the pathway 
involving relationship functioning to psychological IPV (standardized indirect effect = 
.03, p < .01). Collectively, the findings from Schumm et al (2011) show the pathways to 
IPV are complex and at times gender-specific; more specifically, both partners' 
antisociality/generalized violence, substance use, and overall relationship adjustment are 
key to understanding IPV among women entering substance misuse treatment.  
El-Bassel et al (2005) examined whether the frequent drug use increased the 
likelihood of subsequent sexual or physical IPV and whether IPV increases the likelihood 
of subsequent frequent drug use. This article used a random sample of 416 women who 
were recruited from a methadone maintenance treatment facility in New York City, New 
York. This study utilized propensity score matching and logistic regression analyses to 
test three hypotheses, they included: H1) that frequent drug use increases the likelihood of 
IPV; H2) that IPV increases the likelihood of subsequent frequent drug use; and H3) the 
relationship between frequent drug use and IPV is reciprocal. 
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For hypothesis 1, women who used crack at least once a week were more than 4 
times as likely to report physical or sexual IPV compared to women who did not report 
using any drugs or binge drinking (OR = 4.4; 95% CI = 2.1-9.1; p < .01); similar results 
were found for marijuana (OR = 4.5; 95% CI = 2.4-8.4, p < .01). Results also indicated 
that women who reported cocaine use did experience higher rates of IPV, but this result 
did not reach statistical significance. For hypothesis 2, women who reported physical or 
sexual IPV were more likely than women who did not report IPV to indicate frequent use 
of heroin (OR = 2.7; 95% CI = 1.1-6.5, p < 0.4). Near significant findings were found for 
an increased likelihood of frequent crack use (p < .06), marijuana use (p < .07), and 
cocaine use (p < .11). Therefore, hypothesis 3 was not supported at a 95% level of 
confidence, yet hypothesis 1 and 2 were indicative of crack and marijuana use; 
suggesting that the relationship between frequent drug use and IPV is bidirectional and 
varies by type of drug. 
Chermack et al (2002) examined the relationship between violence severity and 
alcohol and cocaine consumption among a sample of substance abuse treatment clients (n 
= 125 women, n = 125 men) in Michigan. Repeated measures ANOVAs and regression 
analyses were conducted to test the relationship between violence severity and alcohol 
and cocaine use. Both general alcohol and cocaine use patterns (on days not involving 
significant interpersonal conflict) [F (2,208) =15.11, P<0.001], as well as alcohol and 
cocaine use on the day of the violent incident F (2,208) =3.38, P<0.05], were associated 
with violence severity. Regression analyses revealed that race (β = 0.23), age (β = -0.16), 
and both general drinking (β = 0.28) and cocaine use patterns (β = 0.18) were positively 
associated with violence severity for the most severe violent incident reported. Similarly, 
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regression analyses focusing on alcohol and cocaine use on the day of the most severe 
incident revealed that higher drinking levels, younger age, minority status, and the 
interaction of alcohol and cocaine use have a significant positive associated with violence 
severity. Chermack et al (2002) posited that these findings suggest the need for 
implementation of routine screening and intervention protocol aimed at violence-related 
problems in substance abuse treatment settings.  
Schneider et al. (2009) examined the prevalence rates and correlates of IPV 
victimization among a national sample of men and women in substance abuse treatment. 
This article used secondary data from the National Treatment Improvement Evaluation 
Study (NTIES) where men (n = 4,459) and women (n = 1,774) were recruited across 71 
treatment sites between July 1993 and November 1994. Bivariate relations between 
demographic, substance use, and child abuse variables and lifetime IPV victimization 
were tested separately by gender. Demographic, substance use and child abuse variables 
that were significant (p < .05) at the bivariate level were included as covariates in the 
logistic regression model. Results indicate that nearly 1 in 2 women and 1 in 10 men 
reported lifetime victimization by an intimate partner.  
Lifetime IPV victimization was reported by 46.7% of women (n = 828) and 9.5% 
of men (n = 422). Bivariate logistic regression results indicated that women at or above 
the median age of 32 (OR = 1.37; CI = 1.12-1.64, p < .01) women without a high school 
diploma or GED (OR = 1.25; CI = 1.04-1.51, p < .001), and women who had been 
married (OR = 1.91; CI = 1.57-2.31, p < .001) were more likely to report lifetime IPV 
victimization; Black women were less likely (OR = 0.67; CI = .54-.83, p < .001) to report 
IPV victimization relative to non-Black, non-Hispanic women. Relative to women 
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entering treatment for drug abuse only, women entering treatment for alcohol abuse (or 
alcohol and drug abuse) were more likely to report IPV victimization (OR = 1.55; CI – 
1.28-1.88). Cocaine, “crack”, heroin, and marijuana use did not correlate to IPV. The 
admission of drug use was significant, as injection drug use was associated with IPV 
victimization in bivariate analyses (OR = 1.47; CI = 1.21-1.79).  
In addition, women with a history of child physical (OR = 4.61; CI = 3.45-6.17) 
or sexual abuse (OR = 2.48; CI = 2.00-3.08) had greater odds of experiencing 
victimization by an intimate partner. In multivariate analyses with women, IPV 
victimization was associated with greater odds of reporting symptoms of anxiety (aOR = 
1.58; CI = 1.27-1.96, p < .001), depression (aOR = 1.54; CI = 1.21-1.96, p < .001), and 
psychosis (aOR = 1.51; CI = 1.22-1.87, p < .001) as well as suicidal ideation (aOR = 
1.69; CI = 1.37-2.09, p < .001) and lifetime suicide attempt (aOR = 1.73; CI = 1.39-2.16, 
p < .001). After adjusting for covariates, IPV victimization was also associated with 
greater odds of reporting recent circulatory, neurological, and bone or muscle problems 
and an STD among women. These findings build on the understanding that IPV among 
women in substance misuse treatment warrants a nuanced examination, and one that 
expects variation by gender. 
Psychopharmacologic Violence among Criminal Justice-Involved Women 
Stuart et al. (2008) analyzed the role of illicit substance use in IPV and examined 
the potential influence of overall and specific illicit substance use on IPV perpetration in 
men and women arrested batterers and their relationship partners. The sample consisted 
of males (n = 271) and females (n = 135) who were at least 18 years-of-age, who were 
arrested for violence, and who were court-referred to batterer intervention programs. The 
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analytical plan of this study included several analyses to test whether the addition of drug 
use variables significantly increased the model's ability to predict psychological and 
physical victimization. First, structural equation models (SEM) were constructed to 
examine model fit for men and women. Two sets of analyses were used in SEM; the first 
set examined how overall drug use predicted IPV relative to other variables, and the 
second set examined how specific drug use (i.e., marijuana, sedative, and stimulant) 
became separate predictors of IPV. For both sets, confirmatory factor analyses (CFA) 
were conducted to assure the factor structures adequately describe latent variable 
indicators, to fit the CFA into a larger structural regression model and to involve 
supplementary analyses by comparing models in which the drug use variables have direct 
paths to victimization with one in which those paths did not have direct effects.  
Demographic analyses found that use of any drug by female partners of male 
perpetrators (33%) was substantially lower than that for male perpetrators (54%), female 
perpetrators (59%), and male partners of female perpetrators (56%). Four of the five 
significant drug-to-victimization paths varied by gender. For male perpetrators, the paths 
from their marijuana use (.10, p < 0.05) and stimulant use (.10, p < 0.05) to their own 
physical aggression was significant. For female perpetrators, none of the drug use 
variables showed any significant effects on the aggression variables. Male perpetrator's 
reports of their female partners’ sedative use (.08, p < 0.05) were associated with their 
reports of their partners’ psychological aggression, whereas the male’s reports of their 
partners’ stimulant use (.07, p < 0.05) were associated with their reports of their partners’ 
physical aggression. Female perpetrators’ results showed that only their reports of their 
partners’ stimulant use were a significant predictor; where, male partner stimulant use 
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was associated with both his psychological (.15, p < 0.05) and physical aggression (.08, p 
< 0.05). These results provide further evidence that drug problems by both partners may 
be important in the evolution of aggression. 
Sheehan et al. (2013) aimed to compare men and women based on the presence of 
drugs when considering deaths that were attributable to homicides and suicides. Data 
were used from the Colorado Violent Death Reporting System (COVDRS), which is 
conducted by the Colorado Department of Public Health as a participant in the National 
Violent Death Report System (NVDRS) and funded by the Centers for Disease Control 
and Prevention. Data spanned from 2004-09 and included N=5,791 violent death victims 
among individuals aged 18 years and older. Researchers used a logistic regression to 
investigate the associations between the presence of substance use (i.e., alcohol, 
amphetamines, antidepressants, cocaine, marijuana, and opiates) and type of death (i.e., 
homicide or suicide). Comparisons were also made between individuals' sex, age, 
race/ethnicity, and educational attainment. The type of violent death was used as the 
outcome variable and it was coded as 1 = homicide and 0 = suicide.  
The results underscored strong associations between drug use and type of violent 
death, as well as significant gender differences. Compared with suicide decedents, 
homicide decedents are significantly more likely to test positive for amphetamines (OR = 
1.79; CI = 1.34-2.39], marijuana (OR = 2.03; CI: 1.60-2.58) and cocaine (OR: 2.60 = CI: 
2.04-3.31) and are less likely to test positive for opiates (OR = 0.27; CI = 0.18-0.39) and 
antidepressants (OR = 0.17; CI = 0.10-0.28). For women, only cocaine indicated a 
significant association with homicide as it increased the odds of death by homicide than 
by suicide (OR = 1.96; CI = 1.11-3.45, p < .05). The presence of antidepressants in 
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women increased their odds of death from suicide compared with homicide by ~12 times. 
Drugs associated with homicide (marijuana, cocaine and amphetamines) are stronger 
among males, while drugs associated with suicide are stronger among females 
(antidepressants and opiates). Taking these differences into consideration may allow for 
targeted interventions to reduce violent deaths.  
Psychopharmacologic Violence among Women in Mental Health/Medical 
Populations 
Gilbert et al. (2012) examined the temporal and bidirectional associations 
between different types of substance use and different types of IPV among a sample (N = 
241) of urban women receiving emergency room care. The sample was collected from a 
New York City Emergency Department in the Bronx, where 90% identified as Latino or 
African American, and nearly one-third lived below the poverty level. This article applied 
a theoretical framework – the ecological perspective – to allow the researchers to 
conceptualize the multilevel risk and protective factors that were associated with 
substance use and IPV among women.  
This longitudinal study was organized in three waves; such as, wave 1 was 
baseline, wave 2 was at the 6-month follow-up mark, and wave 3 was at the 12-month 
follow-up mark. This authors of this study outlined two hypotheses for their study. 
Hypothesis 1 aimed to use of different illicit drugs and binge drinking at Wave 1 
increases the subsequent likelihood of experiencing different types of IPV at subsequent 
Wave 2 (6-month follow-up) and/or Wave 3 (12-month follow-up), after adjusting for 
sociodemographic, multilevel risk and protective covariates, and the baseline indicator of 
IPV outcome using modified Poisson regression and propensity score weighting. 
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Hypothesis 2 aimed to investigate if the experiences of different types of IPV at Wave 1 
increases the likelihood of subsequent use of different drugs and binge drinking at Waves 
2 and/or 3, after adjusting for sociodemographic, multilevel risk and protective 
covariates, and baseline indicator of substance use outcome using modified Poisson 
regression and propensity score weighting.  
Hypothesis 1 was partially supported with significant findings. At Wave 1, results 
indicated that 43.2% of women reported using illicit drugs within the previous 6-months. 
Moreover, 33.2% reported marijuana use, 12.9% reported crack or cocaine use, and 7.5% 
reported heroin use. At Wave 3, illicit drug use was reported at 33%, with marijuana 
being the largest decrease in reported use – heroin, crack/cocaine, and other "hard drugs" 
remained more consistent. The results from hypothesis one revealed several significant 
results. Presented as risk ratios (RR), women who reported heroin use at Wave 1 were 
about twice (RR = 2.1; CI = 1.2-3.6; p < .05) were more likely to report IPV and to report 
injuries (RR = 2.7; CI = 1.1-6.5; p < .05). Compared to women who did not report 
crack/cocaine use at Wave 1, women who reported crack/cocaine use at Wave 1 were 
about twice (RR = 2.4; CI = 1.2-4.7; p < .05) as likely to report injurious IPV and about 
twice as likely to report severe verbal abuse (RR = 2.01; CI = 1.2-3.3; p < .05).  
Collectively, the use of “hard drugs” (i.e., heroin, cocaine and “crack” cocaine) 
was found to increase the likelihood of experiencing all types of any IPV (RR = 1.6; CI = 
1.1-2.4, p < .05), physical IPV (RR = 1.7; CI = 1.1-2.6), injurious IPV (RR = 3.0: CI = 
1.4-6.4, p < .01). Hypothesis 2 was also partially supported with significant findings. 
That is, women who reported sexual IPV at Wave 1 were nearly three-times more likely 
to have reported the use of crack or cocaine (RR = 3.3; CI = 1.1-9.5, p < .05) and nearly 
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twice as likely to report the use of “hard drugs” (RR = 2.4; CI = 1.2-4.8, p < .05) at 
subsequent Waves. The findings in this study underscore the importance of understanding 
the bidirectional ways that substance use and IPV interact. This study also describes the 
importance of having substance use- and IPV-related screening tools that are specified to 
ED settings.  
Systemic Violence among Justice-Involved Women 
Weir et al. (2008) examined the prevalence and correlates of IPV and other 
violence (OV) among justice-involved women (N = 529) who were identified as being at 
high-risk for HIV/AIDS. Women were eligible if they reported (a) being at least 18 years 
old, (b) having been incarcerated in the past year or currently being on parole or 
probation, and (c) engaging in HIV risk behavior (injection drug use, crack use, 
intercourse with a male IDU, exchanging sex, or having had 10 or more sexual partners) 
in the past year. Results indicated that 44% of this sample reported substance use in the 
past 30-days. The substance use profile includes: alcohol (65.2%); marijuana (34.8%); 
crack cocaine (30.0%); amphetamines (28.4%); heroin (24.0%); and cocaine (20.2%). 
Among participants who reported substance use in the past 30-days, 15.7% reported IDU.  
Substance use was significantly associated with IPV and OV. Specifically, 
alcohol or marijuana use meant a participant was nearly twice as likely to be a victim of 
IPV (OR = 1.85; CI = 1.02-3.36, p < .05), and the use of other drugs (i.e., crack cocaine, 
cocaine, amphetamines, and heroin) revealed similar results (OR = 1.95; CI = 1.19-3.18, 
p < .05). Injection drug use was also significantly associated with IPV (OR = 1.75; CI = 
1.05-2.94, p < .05). Other violence (OV) was also associated with substance use; for 
instance, alcohol and marijuana use (OR = 1.61; CI = 0.79-3.30, p < .05), other drug use 
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(OR = 2.10; CI = 1.19-3.71, p < .05), and IDU (OR = 2.05; CI = 1.13-3.71, p < .05). 
These results indicated that the risk of violence victimization, and subtypes of violence 
victimization (IPV vs. OV) is identifiable based on the type of substance used. Therefore, 
effective interventions must address the complexity of the drugs violence nexus, as well 
as the host of other non-substance-use-related associations of violence as identified in this 
article. 
Systemic Violence among Illegal Economy Working Women 
Surratt et al. (2004) examined how the subculture of violence impacts women 
who work as sex workers in Miami, Florida. This article utilized a community-based 
sample that was recruited by using targeted sampling techniques. Specifically, sex 
workers that were crack cocaine- and heroin-using individuals were recruited through 
street outreach and via an HIV-prevention research program. Participant interviews 
included standardized instruments that focused several personal histories, including: 1) 
drug- and sexual-related risk for HIV; 2) sex work; 3) violence; 4) childhood trauma; and 
5) health status. Histories of childhood trauma (i.e. lifetime) and substance use (i.e., past 
month and past year) were the independent variables, and violent victimization(s) was the 
dependent variable.  
The analyses included univariate and bivariate frequency, descriptive, and chi-
square tests. The findings indicated that among this sample of sex workers, 75.4% were 
currently using alcohol, 57.8% were currently using marijuana, 38.4% were currently 
using cocaine, 74.4% were currently using crack cocaine, 19.4% were using heroin, and 
13.8% were currently injecting drugs. Approximately half of the respondents reported 
physical (44.9%) and/or sexual (50.5%) abuse as children, while nearly 40% experienced 
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violence from clients in the prior year: 24.9% were beaten, 12.9% were raped, and 13.8% 
were threatened with weapons. Consistent relationships between historical and current 
victimization suggest that female sex workers experience a continuing cycle of violence 
throughout their lives.  
Economic-Compulsive Violence among Justice-Involved Women 
Oser et al. (2009) sought to examine the drugs/violence nexus among rural felony 
probationers (N = 800). Data for this study was obtained over a 3.5-year period where 
probationers were recruited by trained interviewers in probation offices in Appalachian 
Kentucky. Females were over-sampled at 30% to ensure adequate representation and to 
facilitate a sufficient sample size for data analyses. In this study, violence victimization 
was measured by either being “beaten up and/or someone using a knife or firing a gun at 
the participant.” Violent perpetration was measured by either the participant “beating 
someone else up and/or using a knife or gun on someone.” Independent variables 
included demographic characteristics (i.e., gender, marital status, age, and education), 
psychopharmacological measures (i.e., alcohol, cocaine/crack, and 
amphetamine/methamphetamine), economic compulsive measures (i.e., engaged in crime 
to pay for drug expenses, and number of lifetime arrests) and systemic measure (i.e., 
committed a weapons offense and ever sold or trafficked drugs in lifetime). 
Two dependent variables were used, if the participant had been a victim of violent 
crime (1 = yes; 0 = no) or ever committed a violent crime (1 = yes; 0 = no). Analyses 
included tests of chi-square and one-way ANOVA to measure group differences, and a 
series of binary logistic regressions were used to determine the impact the independent 
variables had on being a victim of a violent crime. For group comparison, participants 
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were grouped in four groups based on the following: 1) never been involved in violent 
crime; 2) victim of a violent crime; 3) perpetrator of a violent crime; and 4) both victim 
and perpetrator of violent crime.  
Bivariate results indicated that females comprised 63.8% of the violent 
victimization group, but only 27% of the violent perpetrator group (χ2 (3) = 66.57; p < 
.001). Among the psychopharmacological measures, participants who were both a violent 
perpetrator and a victim were more likely to define themselves as an alcoholic (χ2(3) = 
27.16, p < .001), to have used cocaine/crack (χ2(3) = 47.79, p < .001), and to have used 
any stimulant other than crack or cocaine (χ2(3) =56.74, p < .001). Among the economic 
compulsive variables, an average of 12.7 lifetime arrests were found among participants 
who were both a perpetrator and a victim, compared to 4.6 in the neither group, 7.0 in the 
victim group, and 5.7 in the perpetrator group (F (3) = 14.97, p < .001). In addition, 
participants who identified as both a perpetrator and a victim in a violent crime were 
significantly more likely to have engaged in crime to pay for drugs and/or living expenses 
(F (3) = 7.93, p < .001). Among the systemic variables, participants who were both 
violent perpetrators and victims were most numerous among those who had ever 
committed a weapons offense (χ2(3) = 36.56, p < .001). Nearly 62% of the both group 
reported selling or trafficking drugs as compared to about two-thirds of the neither group 
(40.2%) (χ2(3) = 34.68, p < .001).  
The full multivariate model results for violent perpetration included the 
demographic, psychopharmacological, economic compulsive, and systemic measures for 
violent perpetration. For females, those with high school diplomas or GEDS were less 
likely to be violent perpetrators (OR= 0.70; CI = 0.50-0.99, p < .05). Lifetime stimulant 
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use predicted an increased likelihood of having ever committed violent crime (O.R. = 
1.60; CI = 1.09-2.37, p < .05). The number of lifetime arrests was positively correlated 
with having ever committed a violent crime across the lifespan (O.R. = 1.02; CI = 1.00-
1.04, p < .05).  
The full multivariate model results for violent victimization based on marital 
status coefficient remained stable across the four models with married participants being 
less likely to have been violently victimized in their lifetime. Participants who identified 
as alcoholics (O.R. = 1.86; CI = 1.11-3.09, p < .05) and those who reported having ever 
used stimulants other than crack or cocaine (O.R. = 1.91; CI = 1.30-2.80, p < .01) were 
nearly twice as likely to have been subjected to violent victimization. A positive 
significant association was found between criminal violent victimization and the number 
of times an individual was arrested (O.R. = 1.05; CI = .74-1.48, p < .01). These findings 
illuminate the unique components of rural violence. The multivariate analyses supported 
the economic compulsive model among both perpetration and victimization of violence. 
Disparate fields of study (i.e., sociology; public health; social work; psychology; 
criminal justice) have provided evidence that women and men are involved in violent 
events at similar rates, and that drug use often plays a critical role in these experiences. 
For women, strong associations between drug use and violence have been found in recent 
years. The current literature indicates that opportunities for involvement in drug-related 
violence victimization occur within complex interactions between social and 
environmental contexts. For many women, violent victimization typically occurs within 
community settings or intimate relationships, and violent perpetrators are often known by 
the victim. These experiences often place them in medical (e.g., emergency room), SUD 
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treatment, and criminal justice (e.g., county jail) settings. Having said that, the magnitude 
of drug use and co-occurring problems is considerably greater among justice-involved 
women.  
Although highly variable, the type of drugs used, and the severity of use were 
associated with experiences of violent victimization. Among female victims, there is 
support for the presence of psychopharmacological violence. Two drug classes were 
highly prevalent in their associations with psychopharmacological violent victimization – 
opioids (i.e., NMPO & heroin) and stimulants (i.e., methamphetamine/amphetamine and 
cocaine). Economic-compulsive and systemic violence among women is also supported 
by recent literature, albeit less so compared to psychopharmacological violence.  
Although it is generally accepted that there is a relationship between drug use and 
violent victimization, the direction of this relationship is less clear. In general, the 
findings in the literature are mixed. There is evidence that drug use (El-Bassel et al., 
2005; Testa et al., 2003) and alcohol use may precede abuse by an intimate partner, or a 
member of the community (Devries et al., 2014). In addition, curtailment of substance 
use has indicated a reduced risk of subsequent victimization (Cohen, Field, Campbell, & 
Hien, 2013). Conversely, there is evidence that experiencing IPV is related to later drug 
use (El-Bassel et al., 2005), or that violent victimization and substance use may have a 
bidirectional relationship. For example, a 2-year longitudinal study utilizing a nationally 
representative cohort of women found that following a physical or sexual assault, 
women’s alcohol and drug use increased, including among women with no previous 
substance use and no prior victimization history. Moreover, women’s substance use was 
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associated with an increased risk of experiencing a subsequent physical or sexual assault 
(Kilpatrick et al., 1997). 
Collectively, despite a high quantity of recent research investigating drug use and 
violence among women, few studies have directly applied Goldstein’s (1985) conceptual 
framework to a rural vulnerable population (i.e., justice-involved women). Moreover, no 
studies to date have investigated how subtypes (i.e., psychopharmacological, economic-
compulsive, and systemic) of drug-related violence may be associated with behavioral 
health risk factors. It is important to examine justice-involved women from Kentucky 
because compared to U.S. rates, the region of Appalachian Kentucky has high rates of 
past-month illicit drug use (excluding cannabis) and high rates of incidents related to 
poor behavioral health and infectious disease (SAMHSA, 2014).  
Current Study 
The current study will analyze existing data from a cohort of justice-involved 
women from jails located in central Appalachia Kentucky. The substance misuse and 
violence relationship among rural justice-involved women has largely been unexplored 
by the current literature. Although research investigating substance use and co-occurring 
mental health and infectious disease risk factors has been explored (Staton-Tindall, 
2015a), it is unclear how the types of violent victimization experiences may shape these 
risk factors. A fuller understanding the relationship between substance use and violence, 
and how this relationship extends to a host of mental health and behavioral risk factors 
for infectious disease may illuminate specific intervention points that could translate to 
policy- and clinical-level action for rural justice-involved women. In addition, this 
proposed study could inform Goldstein’s (1985) theoretical framework by providing 
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novel drugs/violence nexus data related to justice-involved women, and by postulating 
how behavioral health may be impacted by each theoretical domain – a concept that has 
largely been unexplored within this theoretical framework (Goldstein, 1998). 
This study will utilize deductive methods to test Goldstein’s (1985) tripartite 
conceptual framework to extend previous research and to evaluate this framework 
according to a unique and vulnerable population. The focus of Goldstein’s (1985) 
tripartite conceptual framework will be placed on investigating how the current sample is 
grouped (i.e., psychopharmacologic group; economic compulsive group; or systemic 
group), and how these groupings are associated with selected health-related outcomes. 
Three research questions will be explored in this study.  
Research Questions and Hypotheses 
Research Question 1: Can distinct drugs/violence nexus groups be predicted 
based on psychopharmacological factors, economic compulsive factors, and systemic 
factors among a sample of rural justice-involved women?  
Ha1: There will be significant predictors of group membership across the three 
predicted drugs/violence nexus groups and a greater prevalence of participants will be 
observed in the psychopharmacologic group.  
Research Question 2: What are the associations between mental health 
symptomology and the predicted groups (i.e., psychopharmacologic; economic-
compulsive; systemic) groups?  
Hb1: Among each of the predicted groups, there will be a greater number of 
significant associations between mental health symptomology and the 
psychopharmacologic group.  
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Research Question 3: What are the associations between behavioral risk factors 
for infectious disease and the predicted groups? 
Hc1: Among each of the predicted groups, there will be a greater number of risk 
factors among the psychopharmacologic group, given that this grouping entails 
participants directly administering drug use, thus increasing the likelihood of risk for 
infectious disease. 
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Chapter III: Methods 
Data Source 
Data for this study was obtained from a longitudinal project (National Institute on 
Drug Abuse, [NIDA] 1R01-DA033866) called the Women’s Intervention to Stop 
HIV/Hepatitis C (WISH). This project focused on high-risk drug use and risky sexual 
practices among a randomly selected group of rural incarcerated women located in 
Appalachian jails. To enroll in this study, participants had to meet the following 
eligibility criteria: 1) National Institute on Drug Abuse (NIDA, 2010) modified Alcohol, 
Smoking and Substance Involvement Screening Test (ASSIST) scores of four or greater 
indicating the need for substance abuse intervention; 2) engaged in at least one high-risk 
sexual practice in the 3-months prior to incarceration; 3) resided in designated 
Appalachian county before incarceration; and 4) indicated a voluntary willingness to 
participate in the study. The WISH study has been approved by the University of 
Kentucky Institutional Review Board. Due to concerns regarding protecting the identities 
of vulnerable participants, a federal certificate of confidentiality was obtained to further 
ensure that privacy standards were upheld.  
Procedures 
All study recruitment and data collection procedures were approved by the 
university institutional review board and protected under a federal Certificate of 
Confidentiality. Drug-using women were recruited from three rural jail facilities located 
in Appalachian counties. The jails were similar regarding size, female populations and 
availability of programming and resources. Consent for participation in the project was 
provided by all participants before study screening procedures. During the 32-month 
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study recruitment, 688 women were randomly selected from the target jails for study 
screening.  
Study screening took place in a large group room in the jail and included 
measures to assess substance abuse (NM-ASSIST; NIDA, 2009), risky sexual practices 
(Wechsberg, Craddock, & Hubbard, 1998), and voluntary willingness to participate. 
Following the screening session, eligible women (n = 440) were invited to participate in a 
more in-depth baseline interview within a period of 2 weeks to assess their substance 
abuse history, risky sexual practices, history of substance abuse treatment, attitudes 
toward the health care system and overall health. During the 2-week period between the 
time of study screening and in-depth interviews, 40 women were released early. 
Interviews were conducted with 400 women by female research staff from the local 
Appalachian area, who were trained on human subjects protections and jail facility 
policies and procedures prior to study implementation. Participants were paid $25 for the 
baseline interview. 
Measures 
The current study proposes a quantitative design to examine theoretical factors 
associated with substance use and violence based on the Goldstein (1985) tripartite 
conceptual framework, to predict group membership within these theoretical concepts, 
and to test for associations between the predicted groups and mental and physical health 
factors. The Global Appraisal of Individual Need–Intake version (GAIN) is a 
standardized instrument package administered for research purposes only, and intended 
to support clinical decision-making for potential diagnoses, placement, treatment 
planning, and service use (Dennis, Titus, White, Unsicker, & Hodgkins, 2003). This 
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study used select subsections of the GAIN for measurement purposes, and specific 
descriptions of those measures are described in the following sections. The GAIN-SPS 
has been found to be highly reliable with adolescents and adults, with alphas ranging 
from .80 to .90. Cronbach’s alpha for the current study is .89. 
To measure substance use, this study used the Alcohol, Smoking, and Substance 
Involvement Screening Test (ASSIST) (Humeniuk et al., 2008). This interview-based 
instrument was developed by the World Health Organization (WHO) to screen across 
substances. It consists of 8 questions that aid in identifying the level of substance use-
related risk to help guide intervention. Among the current sample, the Cronbach’s alpha 
for the ASSIST measure was .81. Each of the measures included in the multivariate 
models are presented in Table 1.  
Demographics 
Demographic variables to be included will be age, marital status, education, 
income, children status, housing, violence victimization, and drug use history. Age was 
measured as an interval measure by number of years. Marital status was measured 
categorically by asking the participants if they were currently with a partner (1 = Yes; 0 = 
No). Education was measured continuously as the highest level of education attainment. 
Income was measured continuously in dollars by asking, “During the six-months before 
incarceration, what was your total income from all sources including work, 
family/friends, government support, etc.?” Participants children status was measured 
dichotomously (1 = Yes; 0 = No). Employment was measured nominally by asking 
participants to report their last job prior to incarceration, values included; 1 = professional 
& technical; 2 = manager and administer; 3 = sales; 4 = clerical or office work; 5 = craft 
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and kindred; 6 = operative; 7 = transportation equipment operative; 8 = nonfarm laborer; 
private household worker; 9 = private household worker; l0 = service worker; 11 = 
farmer and farm manager; 12 = farm laborer; 13 = military service; 14 = fast food 
industry; 15 = construction; 16 other. Housing was measured continuously by asking 
“Number of days in the 6-months before incarceration were you homeless or had to stay 
with someone else to avoid being homeless?” Chronic pain was measure by asking, 
“Does participant have any chronic physical pain that has lasted longer than 3-months (0 
= No; 1 = Yes)?” 
Psychopharmacologic Variables 
The psychopharmacologic variables were measured by using five continuous 
substance use variables. These variables were taken from the NIDA-Modified Alcohol, 
Smoking and Substance Involvement Test (ASSIST) (Humeniuk et al., 2008). Drug use 
that was included in this study included prescription opioids, prescription stimulants, 
prescription sedatives, heroin, methamphetamine and cocaine. The ASSIST scoring range 
is as follows: 0-3 = low risk; 4-27 moderate risk; and 27+ high risk.  
Participants were asked about their lifetime and past 3-months drug use prior to 
incarceration. Questions 1 to 7 ask about drug use and related problems. Question 1 asks 
about which substances have ever been used in the participant’s lifetime. Question 2 asks 
about the frequency of substance use in the past 3-months to give an indication of the 
substances that are most relevant to current health status and use patterns. Question 3 
asks about the frequency of experiencing a strong desire or urge to use each substance in 
the past 3-months. Question 4 asks about the frequency of health, social, legal or 
financial problems related to substance use in the past 3-months. Question 5 asks about 
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the frequency with which each substance has interfered with personal responsibilities in 
the past 3-months. Question 6 asks if anyone has ever expressed concern about the 
participant’s substance use in their lifetime, and how recently that occurred. Question 8 
concerns IDU and asks whether the participant had ever injected any drug (Humeniuk et 
al., 2008).  
Economic-Compulsive Variables 
The economic-compulsive component was measured using one continuous 
variable and one dichotomous variable that targeted the extent to which drug-related 
illegal activity occurred because of economic necessity. Participants were asked, “How 
many days in the past 3-months prior to incarceration they engaged in illegal activities for 
profit?” In addition, participants were asked, “In the past year, did you ever have sex with 
a partner in exchange for money or drugs (1 = Yes; 0 = No)?” 
Systemic Variables 
The systemic domain was measured using two ordinal variables that targeted the 
social and transactional elements of illegal activity that can have limited social control 
mechanisms. First, participants were asked, “How often a friend traded, sold, or dealt 
drugs in the 6-months prior to their arrest date (1 = Never; 2 = Sometimes; 3 = Often)?” 
Second, participants were asked, “How often a friend did other things against the law in 
the 6-months prior to their arrest date (1 = Never; 2 = Sometimes; 3 = Often)?”  
Grouping Variable 
Violence victimization were used as the grouping variable in the discriminant 
function analyses. To measure violence victimization participants were asked, “If anyone 
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had ever hurt them by striking or beating them to the point they had bruises, cuts, or 
broken bones (1 = Yes; 0 = No)?” 
Risk Behaviors for Infectious Disease 
Two dichotomous variables and one continuous variable were selected to measure 
participant’s risk factors for acquiring or diffusing an infectious disease. These measures 
were operationalized using questions from the GAIN-Risk Behaviors Screener (RBScr). 
Specifically, participants were asked about their sexual history while under the influence 
of alcohol or drugs, their history of sharing needles, and by who initiated them to IDU. 
To measure past 12-months condom use during intercourse with male partners, 
participants were asked, “Did you use a male condom in the past 12-months prior to your 
incarceration (1 = Yes; 0 = No)?” To measure initiation to IDU,  participants were asked, 
“Boyfriend/male lover: Who shot up with the first-time injecting (0 = No; 1 = Yes). To 
measure history of syringe sharing behavior, participants were asked “How many people 
did you share needles within the past year?”  
Mental Health Symptomology Variables 
Four dichotomous variables were selected to measure participant’s mental health 
symptomology. Mental health was measured using the GAIN-Internalizing Disorders 
Screener (IDScr). This screening tool is meant to identify “significant” mental health 
problems, as defined by problems that last for two or more weeks, that are recurring, that 
keeps the participant from meeting their responsibilities, or that makes the participant feel 
like they cannot go on (Dennis, et al., 2003).  
The measurements included in this section were conceptual indicators for 
symptomology of the following: 1) Depression; 2) Anxiety; 3) Suicidal Ideation; and 4) 
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Psychosis. Participants were asked the following questions: 1) “In the past 12-months, 
have you had significant problems with feeling trapped, lonely, sad, blue, depressed, or 
hopeless about the future (1 = Yes; 0 = No)?”; 2) “In the past 12 months, have you had 
significant problems with feeling very anxious, nervous, tense, scared, panicked or like 
something bad was going to happen (1 = Yes; 0 = No)?” 3) “In the past 12 months, have 
you thought about ending your life or committing suicide (1 = Yes; 0 = No)?”; 4) “In the 
past 12 months, have you had significant problems with seeing or hearing things that no 
one else could see or hear or feeling that someone else could read or control your 
thoughts (1 = Yes; 0 = No)?” 
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Table 1: Variables Used in Multivariate Analyses 
Psychopharmacologic Measurement 
Temporality 
Measurement 
Type 
Values 
Prescription Opioid Past 3-
Months/Lifetime 
Continuous 
 
Prescription Stimulant Past 3-
Months/Lifetime 
Continuous 
 
Prescription Sedative Past 3-
Months/Lifetime 
Continuous 
 
Heroin Past 3-
Months/Lifetime 
Continuous 
 
Methamphetamine Past 3-
Months/Lifetime 
Continuous 
 
Cocaine Past 3-
Months/Lifetime 
Continuous 
 
Economic-Compulsive 
   
Illegal Activities for 
Profit 
Past 3-Months Continuous 
 
Trade Sex for 
Drugs/Money 
Past 12-Months Dichotomous 0 = No; 1 = Yes 
Systemic 
   
Friend Dealt Drugs Past 6-Months Ordinal 1 = Never; 2 = Sometimes; 
3 = Often 
Friend Other Illegal 
Activity 
Past 6-Months Ordinal 1 = Never; 2 = Sometimes; 
3 = Often 
Grouping Variable 
   
Violent Victimization Lifetime Dichotomous 0 = No; 1 = Yes 
Risk Factors for 
Infectious Disease 
   
Used Male Condom Past 12-Months Dichotomous 0 = No; 1 = Yes 
IDU Initiation Lifetime Dichotomous 0 = No; 1 = Yes 
Syringe Sharing Past 12-Months Continuous 
 
Mental Health 
Symptomology 
   
Depression Past 12-Months Dichotomous 0 = No; 1 = Yes 
Anxiety Past 12-Months Dichotomous 0 = No; 1 = Yes 
Suicide Ideation  Past 12-Months Dichotomous 0 = No; 1 = Yes 
Psychosis Past 12-Months Dichotomous 0 = No; 1 = Yes 
 
Analytic Plan 
Demographic characteristics were presented using descriptive and frequency 
analyses. Theoretical groups were examined by conducting a series of multivariate 
analyses that included discriminant function analyses and binary logistic regression 
51 
 
analyses. The discriminant function analyses were performed to determine if the predictor 
variables could differentiate the sample based on membership to the 
psychopharmacologic model, the economic-compulsive model, or the systemic model. 
This analytical step allows for an examination of the sensitivity for each discriminant 
function analysis in accurately predicting the theoretical models (Poulsen & French, 
2008).  
In addition, a series of binary logistic regressions were conducted with the same 
predictor variables. This analytical step allows for an examination of the specificity of 
each discriminant function analysis, by identifying which predictors were the strongest 
associates of each theoretical model (Poulson & French, 2008). The second and third 
research questions were examined by conducting a series of binary logistic regression 
analyses. The theoretical models (i.e., psychopharmacologic, economic compulsive, and 
systemic) functioned as outcomes for the behavioral risk factors of infectious disease 
contraction and mental health risk factor predictor variables. Analyses were conducted 
using SAS version 9.4 and SPSS version 25. 
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Chapter IV: Results 
Demographics 
Among the overall sample (N = 400), there were 87 participants who were 
predicted to more than one group following the discriminant function analyses. To 
mitigate concerns of shared variance, these participants (n = 87) were removed from 
subsequent multivariate analyses; however, they were included in the demographic 
characteristics. Participants were on average 32.8 years old, had an 11th grade education, 
were homeless 13.5 days in the year prior to incarceration, and over the 6-months prior to 
incarceration the reported income was $8,467. Most participants were White (98.1%), 
had children (86.8%), and had a history of violence victimization (64.5%) (see Table 2). 
 
Table 2: Demographic Characteristics (N=400)  
Mean (SD)% Range 
Age 32.8 (8.2) 18-61 
Race   
% White 98.1%  
Married 32.0%  
Education 11th grade  
All Past 6-Month Income $8,467 ($18,558)  
Children 86.8  
Homelessness 13.5 days (42.3) 0-180 
Violence Victimization 64.5%  
Psychopharmacologic Variables   
Cannabis SI Score 12.2 (11.9) 0-39 
Cocaine SI Score 8.4 (11.9) 0-39 
Heroin SI Score 9.2 (14.2) 0-39 
Methamphetamine SI Score 15.4 (15.3) 0-39 
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Table 2 (continued) 
Prescription Opioid SI Score 27.8 (13.8) 0-39 
Prescription Sedative SI Score 19.9 (14.8) 0-39 
Prescription Stimulant SI Score 6.7 (10.8) 0-39 
Economic-Compulsive Variables 
 
Days of Illegal Activities for Profit  77.4 (83.5) 0-180 
Trade Sex for Drugs/Money 77.8%  
Systemic Variables   
Friend Dealt Drugs   
Never 14.0%  
Sometimes 25.8%  
Often 60.2%  
Friend Other Illegal Activity   
Never 11.3%  
Sometimes 30.6%  
Often 58.4%  
Mental Health Symptomology   
Depression 61.3%  
Anxiety 59.8%  
Suicidal Ideation 10.8%  
Psychosis 22.3%  
Infectious Disease Risk Factors   
Number of People Shared Syringes Past 12-m 3.3 (6.45) 50 
No Condom Use 68.0%  
IDU Initiated by Male Partner 34.8%  
 
Research Question 1 
 A series of discriminant function analyses were conducted to test the extent to 
which predictor variables could predict the psychopharmacologic group, the economic-
compulsive group, and the systemic group relative to violence victimization. Values for 
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sensitivity, specificity, positive and negative predictive power are presented in Table 3. 
The data yielded three significant discriminant models. The correlations between each of 
the predictor variables for the three discriminant models are displayed in Table 3. A 
subsample (n = 77) of participants exhibited considerable overlap in their predicted group 
membership; therefore, they were removed to mitigate sampling error from the 
subsequent analyses. A breakdown of the predicted groupings is presented in Figure 2.  
 
 
Note. Results from the discriminant function analyses 
Figure 2: Drugs/Violence nexus predicted groups (N=313). 
 
Confirming hypothesis 1, the psychopharmacologic model (n = 181) indicated a 
strong discriminatory ability (Klecka, Iversen, & Klecka, 1980) and had the greatest 
proportion of the total sample. Overall, the psychopharmacologic model correctly 
classified 87.5% of the sample and was statistically significant (Wilk’s Lambda = .389, F 
= 3.94, p < 0.001). Among the three discriminant models, the psychopharmacologic 
model was indicated to have had the greatest discriminatory ability. Each of the three 
predictor variables were significant contributors to the model. The largest absolute 
Psychopharmacological
Group (n = 181)
Economic-Compulsive Group
(n = 77)
Systemic Group (n = 55)
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correlate in this model was the illicit use of prescription opioids (Canonical Correlation = 
0.88). 
The economic-compulsive model (n = 77) indicated a moderate discriminatory 
ability (Klecka, Iversen, & Klecka, 1980). Overall, the model correctly classified 79.8% 
of the sample and was statistically significant (Wilk’s Lambda = .584, F = 11.86, p < 
0.001). Both of the predictor variables included in the economic-compulsive model 
significantly contributed to the model. The largest absolute correlate in this model was 
the number of days a participant engaged in illegal activities for profit in the 3-months 
prior to incarceration (Canonical Correlation = 0.86). A strong positive correlation was 
observed between illegal activity for profit and violent victimization.  
The systemic model (n = 55) indicated a moderate discriminatory ability (Klecka, 
Iversen, & Klecka, 1980). Overall, the model correctly classified 71.9% of the sample 
and was statistically significant (Wilk’s Lambda = .492, F = 6.59, p < 0.001). Both of the 
predictor variables included in the system model significantly contributed to the model. 
The largest absolute statistically significant predictor in this model was demonstrated by 
how often the participant’s friends traded, sold, or dealt drugs in the 6-months prior to 
their arrest date (Canonical Correlation = 0.96). A full display of the correlations between 
the remaining predicting variable and the discriminant function are in Table 3. 
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Table 3: Results from Discriminant Function Analyses 
Psychopharmacological 
Group 
Standardized Canonical 
Coefficients 
R-
Square 
F-
Value 
P>F 
Prescription Stimulant 0.356 0.019 7.86 
0.10
5 
Prescription Opioid 0.875 0.018 7.01 
0.00
0 
Prescription Sedative 0.711 0.013 5.01 
0.02
5 
Heroin 0.805 0.032 8.93 
0.00
3 
Methamphetamine 0.537 0.038 15.21 
0.00
8 
Cocaine 0.122 0.024 4.25 
0.44
0 
Economic-Compulsive 
Group 
    
Illegal activity for profit 0.861 0.043 17.35 
0.00
1 
Sex as currency 0.733 0.031 12.42 
0.00
1 
Systemic Group     
Friend's drug dealing 0.448 0.045 16.65 
0.00
1 
Friend's other illegal activity 0.638 0.049 18.28 
0.00
1 
 
Research Question 2 
 A series of binary logistic regression was conducted to examine if mental health 
symptomology was associated with the predicted groups (i.e., psychopharmacologic; 
economic-compulsive; systemic). As presented in Table 4, results of the binary logistic 
regression indicated that there was a significant association between mental health 
symptomology and psychopharmacologic violence (χ²(5, 308)=22.33, p < .001) and 
economic-compulsive violence (χ²(5, 308)=37.67, p < .001), but not for systemic 
violence (χ²(5, 308)=11.76, p < .138). 
  The variable with the strongest association with psychopharmacological violence 
(OR = 2.48; CI = 1.38-4.45, p < .002) was experiencing psychotic symptoms. In addition, 
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hypothesis 2 was not confirmed as economic-compulsive violence was associated with an 
equal number of mental health symptomology, including depression symptoms (OR = 
1.80; CI = 1.10-3.03, p < .027) and suicidal ideation (OR = 1.45; CI = 1.27-3.01, p < 
.032) (see Table 4). There were no significant individual risk factors associated with the 
systemic group.  
Table 4: Binary Logistic Regression Analyses Results for Mental Health Symptomology 
Psychopharmacological Group B OR 95% CI 
Depression 0.502 1.65 1.19-2.77* 
Anxiety -0.312 0.73 0.44-1.21 
Suicidal Ideation -0.353 0.70 0.34-1.45 
Psychosis 0.908 2.48 1.38-4.45** 
Economic-Compulsive Group  
Depression 0.589 1.80 1.10-3.04* 
Anxiety -0.191 0.86 0.50-1.36 
Suicidal Ideation 0.371 1.45 1.27-3.01* 
Psychosis 1.086 0.73 1.70-5.15 
Systemic Group   
Depression 0.063 1.10 0.98-2.62 
Anxiety -0.450 0.97 0.64-1.80 
Suicidal Ideation 0.043 1.04 0.51-2.14 
Psychosis 0.534 1.71 0.99-2.95 
Note. *p < .05; **p < .01 
Research Question 3 
 A series of binary logistic regression were conducted to examine if behavioral 
health risk factors for infectious disease were associated with a discriminant function 
analysis-defined model (i.e., psychopharmacologic; economic-compulsive; systemic). As 
presented in Table 5, results of the binary logistic regression indicated that there was a 
significant association between behavioral health risk factors for infectious disease and 
psychopharmacologic violence (χ²(3, 310)=5.73, p < .05) and economic-compulsive 
violence (χ²(3, 310)=9.99, p < .007). Hypothesis 3 was not confirmed as the 
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psychopharmacological model did not have the greatest number of significantly 
associated infectious disease risk factors.  
 Two variables were significantly associated with psychopharmacologic violence. 
The strongest association with psychopharmacologic violence was having a partner who 
initiated IDU (OR = 9.85; CI = 5.10-30.78, p < .041). The other significant association to 
the psychopharmacological group was not using a condom in the 12-months prior to 
incarceration (OR = 1.62; CI = 1.39-1.98, p < .045) (Table 5).  
 Two variables were significantly associated with economic-compulsive violence. 
The strongest association with economic-compulsive violence was the number of 
individuals that participants’ shared needles with 12-months prior to incarceration (OR = 
2.16; CI = 2.05-3.67, p < .001). This finding indicated that the risk of economic-
compulsive violence increased by approximately twice as the number of times a 
participant shared a needle increased. There were no significant associations between 
infectious disease risk factors and the systemic group (Table 5). 
Table 5: Binary Logistic Regression Analyses Results for Infectious Disease Risk Factors 
Psychopharmacological Participants B OR 95% CI 
Shared Needles 0.019 1.02 .97-1.08 
No Condom 0.474 1.62 1.39-1.98* 
Intro to IDU 2.287 9.85 5.10-30.78* 
Economic-Compulsive Participants  
Shared Needles 0.445 2.16 2.05-3.67*** 
No Condom 0.409 1.51 1.06-2.40* 
Intro to IDU -1.456 0.23 .025-2.17 
Systemic Participants   
Shared Needles -0.069 0.93 .83-1.05 
No Condom 0.201 1.78 1.69-3.62 
Intro to IDU -1.715 1.17 .69-1.98 
Note. *p < .05; **p < .01; ***p < .001 
Copyright © Grant Victor 2019 
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Chapter V: Discussion 
The findings of the current study provided partial support for the study 
hypotheses. To that end, the intent of this chapter is to detail the findings of the current 
study, to discuss policy and treatment implications, to provide guidance for future 
research, and to highlight the role of social workers in meeting the needs of justice-
involved rural women. First, explanations of the current findings are provided and 
compared to past research. Second, implications and translational recommendations are 
summarized generally and from a social work perspective, taking account of both micro- 
and macro-level interventions. Third, limitations of the current study and areas for future 
research are presented. Fourth, a conclusory summary of the current study is provided.   
This study examined the contributing factors that influenced the drugs/violence 
relationship among justice-involved women in Appalachia, and it explored the 
associations between the predicted drugs/violence groups and mental health 
symptomology and behavioral health risk factors. The theoretical framework proposed by 
Goldstein (1985) informed the conceptualization of the drugs/violence relationship types; 
specifically, psychopharmacologic violence, economic-compulsive violence and systemic 
violence. Goldstein’s (1985) framework was supplemented by a feminist perspective 
(Chesney-Lind & Shelden, 2013) given the homogeneity of the current study sample and 
as a means toward explaining the findings and implications of this study. The statistically 
significant findings in this study build upon the existing literature base that has addressed 
justice-involved women (Chesney-Lind & Shelden, 2013; Fogel et al., 2014; Fogel, & 
Belyea, 1999; Oser et al., 2009), and the theoretically guided characteristics (Goldstein, 
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1985) of justice-involved women’s experience of the relationship between drug use and 
violence.  
The sociodemographic characteristics indicated that the current sample had 
structural and social determinants of health that are consistent with the Appalachian 
region in Kentucky (ARC, 2017). The economic inequality among justice-involved 
women in the current study were comparable to the majority of justice-involved 
populations (Deckard, 2017; Rabuy & Kopf, 2015). The majority of the current sample 
had approximately two children and on average had attained an eleventh-grade education. 
According to the ASSIST instrument (Humeniuk et al., 2008), reported drug use of the 
current sample ranged from moderate to severe on each drug class. On average, NMUPO 
and prescription sedatives had the most severe use profiles. The drug use reported by the 
current sample is comparable with most justice-involved individuals, as evidenced by 
(Mumola & Karberg, 2006). Nearly two-thirds of the current sample reported violent 
victimization in the 12-months prior to their incarceration; national estimates for justice-
involved women range between 50% to 98% (Beck, Berzofsky, Caspar, & Krebs, 2013).  
Theoretical Relationship between Drug Use and Violence 
 This study was the first to use Goldstein’s (1985) tripartite conceptual framework 
to examine how psychopharmacologic factors, economic-compulsive factors, and 
systemic factors predicted the drug use and violence relationships among justice-involved 
women. As noted, the majority (64.5%) of justice-involved women in this sample 
reported being a victim of violence in their lifetime. According to the Bureau of Justice 
Statistics (Bronson & Berzofsky, 2017), the majority of justice-involved women do not 
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typically have violent charges (less than 5,000) at the at the county- and national-level. 
Yet, most justice-involved women have been incarcerated on drug offenses.  
Presently, there are 8,500 women in federal prison on drug charges, 24,700 in 
state prisons and 27,000 in local jails (Bronson & Berzofsky, 2017). This offender profile 
coupled with violent victimization histories provides some evidence for the 
drugs/violence relationship among justice-served women. A series of discriminant 
function analyses were conducted to determine if the drugs/violence relationship factors 
could discriminate between psychopharmacologic violence, economic-compulsive 
violence and systemic violence among rural justice-involved women. Overall, the 
findings in the current study indicated that each of the discriminant function analyses 
were statistically significant.  
The current findings provided novel evidence which demonstrated that 
Goldstein’s (1985) conceptual framework did have utility among a sample of rural 
justice-involved women. That is, among a unique subpopulation, the current findings 
indicate there is are direct relationships that demonstrated the impact of 
psychopharmacological, economic-compulsive, and systemic victimization. These 
findings could be helpful in providing a modified conceptual framework to explore 
linkages across a variety of victimization (e.g., domestic violence, sexual assault, 
stalking, or suicide) and rural venues (e.g., crisis center patients, medical care patients, 
substance use treatment clients, or individuals in juvenile detention).  
Building evidence that is specific to rural communities is important, as Kuhns & 
Clodfelter (2009) note, most victimization studies rely on nationally representative 
samples that may not gather accurate information on the victim’s drug use, or reliably 
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identify issues that were specific to unique at-risk populations. Further, the predicted 
groups were examined by using violence victimization as the primary discriminating 
variable, which largely contrasted with much of the male- and perpetration-focused 
development and subsequent testing of Goldstein’s (1985) original framework. This 
study also was the first to provide evidence that unique health risk-factors were 
significantly associated to participants’ specific drug-related violent victimization 
experiences. In other words, the findings of the current study propose of modified 
framework that can be used to guide future research examining drug use and violence 
victimization in rural communities.  
Psychopharmacological Violence 
 The psychopharmacological group had the greatest number of participants 
compared to the other predicted drugs/violence groups. This suggests that the 
psychopharmacological drugs/violence relationship was the most prevalent to affect the 
current sample. Previous research has found similar results, where 
psychopharmacological violence was the most common context of drug-related violence 
(Oser et al., 2009). However, comparisons are difficult because past research has given 
minimal attention to violence victimization and no study has tested this framework 
exclusively on rural justice-involved women.  
Yet, when comparing the current results to past research, the findings of this study 
may indicate that the pervasiveness of psychopharmacologic violence spans across the 
urban-to-rural divide, between men and women, and within the contexts of violence 
perpetration and victimization. Perhaps an explanation for the pervasiveness of this type 
of drug/violence relationship is based on the notion that the psychopharmacological 
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violence is distinct from the other two drugs/violence subtypes (Goldstein, 1985). That is, 
the psychopharmacologic violence designates that the risks for drug-related violent 
victimization exists mainly in the effects of the drugs, rather than within certain socio-
economic contexts (i.e., economic-compulsive or systemic) (Goldstein 1985). 
Compared to the other groups, the psychopharmacologic group also had the 
greatest discriminatory ability which indicated it was the most reliable model in 
predicting the drugs/violence relationship. In the specified discriminant function model 
for psychopharmacologic violence, women who reported NMUPO, heroin use, 
prescription sedative misuse, and methamphetamine use in the 12-months prior to 
incarceration were significantly discriminated between those with violent victimization 
histories and those who did not. NMUPO and heroin use had the strongest correlation to 
violence victimization, and prescription sedative use followed closely behind. These 
findings contrast with much of Goldstein’s (1985) conceptualization of 
psychopharmacological violence. Most of the significant correlates of the predicted 
psychopharmacological group typically produce an acute depression of cognitive and 
psychomotor functioning. Much of Goldstein’s (1985) writing on psychopharmacological 
violence noted the profound effect that stimulant use had on violent behavior. Given 
these discrepancies, the current findings are important considerations for vulnerable rural 
women and for the perspective of survivors of violence rather than perpetrators of 
violence. 
Framed in the context of Goldstein’s (1985) tripartite conceptual framework, the 
finding relative to NMUPO and heroin use is counter to a substantial portion of literature 
involving the drugs/violence nexus. Past research has been largely conceptualized as the 
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perpetration of violent behavior (Boles & Miotto, 2003; Goldstein, 1985; 1998) or 
commitment of violent crime (Basile, 2005; Harrison & Schehr, 2005; Oser et al., 2009). 
NMUPO among the current sample suggests that Goldstein’s framework could be 
adapted to the experiences of rural justice-involved women. To that end, this study 
provides evidence that prescription opioids and heroin may alter an individual’s behavior 
in such a manner as to bring about that individual’s violent victimization. Thus, future 
applications of Goldstein’s (1985) framework with rural justice-involved women may 
consider the unique implications that NMUPO and heroin use have with violence 
victimization.  
Although Goldstein’s (1985) conceptual framework offers a robust explanation 
for the drugs/violence nexus, it may be limited in its applicability to describing 
experiences of victimization and NMUPO, prescription sedative use, and heroin use. The 
relationship between these drugs and violence may be explained in part by bodily pain; 
although, the type or severity of pain was not identified in the current study. In addition, 
if bodily pain was present, it may have been the result of past victimization. Past research 
has found that NPOUs were significantly more likely than nonusers to have a history of 
IPV, and more likely to experiences violent victimization from someone other than their 
intimate partner. An IPV event can also produce symptoms beyond the acute stage; such 
as residual symptoms, which include headaches, back pain, gynecological problems, 
abdominal problems, and chronic disease (Campbell et al., 2002; Coker et al., 2002; Wu, 
Huff, & Bhandari, 2010). Given these findings, and because this study could not directly 
ascertain the temporal events of the drugs/violence relationships, it is possible that the 
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results in the psychopharmacological group were indicative of a circular pattern of drug 
use, violence, and coping with the associated pain symptomology.  
However, methamphetamine use was also significantly associated with 
psychopharmacological group membership. This finding was consistent with past 
research, as existing literature has continued to define and replicate the association of 
stimulant use and violent victimization (Boles & Miotto, 2003; Chermack et al., 2002; El-
Bassel et al, 2005; Goldstein, 1998; Oser et al., 2009). Therefore, the current study 
confirms there was a psychopharmacologic link between stimulant (i.e., 
methamphetamine) use and drug-related violence for this sample of justice-involved rural 
women.  
In general, stimulant use has been found to be associated with symptoms of 
psychosis such as delusions, hallucinations and paranoia (Harris & Batki, 2000), which in 
turn may make an individual more vulnerable to violent victimization. Another plausible 
explanation may be the complex interconnectedness between participants’ substance use, 
their intimate partners’ stimulant use, and the wider dynamics of power and control place 
them at a greater risk violent victimization (Gilchrist et al., 2019; Snell-Rood et al., 
2016).  
Economic-Compulsive Violence 
 There was statistically significant support for the relationship between economic-
compulsive measure and violence victimization. The results from the current study 
indicated that both a history of illegal acts for profit and trading sex for drugs/money 
contributed to predicting economic contexts for violence victimization. Both factors 
included in the economic-compulsive model significantly discriminated between 
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predicted victims of violence to those who were not predicted to be victims of violence. 
On average, the participants who were predicted into the economic-compulsive group 
reported less income compared to the other two groups. Although this income disparity 
was not statistically significant, it may signify an economic gradient effect within a 
sample of predominantly low-income individuals. This economic gradient effect could 
partially explain why certain participants were predicted into the economic-compulsive 
group and their motivations for behavior that placed them at risk for infectious disease 
and mental health issues.  
The number of days a participant engaged in illegal activity for profit was the 
strongest correlate to violence victimization, which is a finding that is corroborated by 
past research involving justice-involved individuals in rural Kentucky (Oser et al., 2009). 
Rural residents might have extensive histories of arrest and illegal activity because of 
their undertreated or untreated behavioral health concerns – including addiction – which 
may in turn impact employment (Browne et al., 2016; Conger, 1997; Victor et al., 2018; 
Warner & Leukefeld, 2001). To that end, in the current study sex work in exchange for 
money and drugs was also a strong correlate of violent victimization.  
Women who engage in sex work are often vulnerable as they are positioned at the 
intersection between victimization and criminality (Shdaimah et al., 2013). Research on 
this topic has showed that many women who engage in sex work suffer from numerous 
chronic and acute behavioral health issues including victimization and trauma, substance 
misuse, mental health disorders, physical health disorders, and structural determinates of 
health (e.g., housing stability and transportation) (Chapkis, 2000; El-Bassel et al., 2001; 
Nussbaum, 2017; Wiechelt & Shdaimah, 2011). Collectively, the risky economic 
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situations identified in this study and others are often drug-related, and can lead to 
victimization (e.g., being a victim of assault during a sexual transaction). It is 
recommended that treatment and policy efforts aimed at improving drug use- and 
violence-related outcomes ought to consider the interconnectedness of both issues as they 
pertain to social and economic determinants of health (Dasgupta, Beletsky, & Ciccarone, 
2018).  
The economic-compulsive model findings may be suggestive of the previously 
mentioned economic distress that has affected many rural regions and especially rural 
Kentucky (ARC, 2017). The Appalachian region of Kentucky has been beleaguered by a 
lack of employment opportunities and static economic growth. In comparison to U.S. 
national averages, Appalachian Kentuckians are at an educational disadvantage as they 
are less likely to have a high school degree (74.1% to 80.4%) or a degree in higher 
education (17.1% to 24.1%). This comports with the current study sample as they on 
average had slightly less than a high school degree.  
Moreover, in Appalachia Kentucky household incomes are more likely to fall 
below the poverty line (14.9% to 12.5%) (ARC, 2017). The current sample were found to 
have similar economic hardship, and consequentially, this may have tilted them toward 
economically based crimes. For justice-involved rural women, not only did their 
economic hardships perhaps orient them to criminal behavior, but it was also found to 
place them at a greater risk for violence victimization, as evidenced by the proportion of 
the sample that were predicted in the economic-compulsive group.  
Using a gender-responsive perspective, the dynamics of an abusive intimate 
relationship may provide another explanation for the predicted economic-compulsive 
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group. It is crucial that SUD treatment providers understand that abusive partners often 
actively destabilize a victim’s personal agency and the resources that may influence 
whether they utilize treatment. For instance, the abuser may use a victim’s addiction as a 
means of control by isolating them from sources of support and by using the stigma of 
addiction to undermine the victim’s credibility. The range of drug use as a means of 
control extends to a victim’s ability to access their own or other’s economic support and 
employment opportunities (Matjasko, Niolon, & Valle, 2013). This scenario would 
plausibly place a victim in precarious economic standing, so higher risk (i.e., sex work 
and other illegal activity for profit) and often illegal means of subsidizing their own 
livelihood and ability to avoid a potentially traumatic withdrawal may be engaged 
(Shdaimah, & Wiechelt, 2013).  
Systemic Violence 
 Overall, the systemic model was significant, and it produced a strong significant 
correlation – the number of times a participant’s friend sold or diverted drugs – in 
predicting drug-related violence. Although past research examining rural probationers has 
failed to find any significant associations between drug use and systemic violence (Oser 
et al., 2009), the current findings were congruent with drug diversion within rural social 
and kinship networks and the role opioids play within the socio-economic context of the 
region. The availability of prescription opioids has increased in the majority of regions in 
the U.S. over the past two decades, and there is evidence suggesting it has had a greater 
increase in rural areas (McDonald, Carlson, & Izrael, 2012). Sales data of prescription 
medication indicate that states with large rural populations (e.g., Kentucky) are among 
the highest for opioid analgesic prescriptions (McDonald et al., 2012).   
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Specifically, opioid analgesics are often prescribed for pain that is a consequence 
of heavy labor, such as mining. In addition, qualitative research from Appalachian 
Kentucky has described opioid use undergirds the work-life functionality of the region 
(Leukefeld, Walker, Havens, Leedham, & Tolbert, 2007). Given the higher density of 
opioid prescribing in rural areas (McDonald et al., 2012), past research has suggested that 
opioids are diverted within family and kinship networks (Green, Serrano, Licari, & 
Budman, 2009; Inciardi, Surratt, Cicero, Kurtz, Martin, & Parrino, 2009), in part so that 
individuals can maintain long periods of manual labor (Leukefeld et al., 2007). However, 
most individuals working in the Appalachian coal industry and heavy labor jobs have 
traditionally been men (ARC, 2017). It may be that economic hardship has strained not 
only the predominantly male workers themselves, but also those in the broader social 
network (e.g., wives, partners, sisters, daughters, etc.). This could in-turn increase the risk 
for illicit drug use and diversion in an area with a high concentration of opioid 
prescribing (Jonas, Young, Oser, & Leukefeld, 2012).  
This systemic environment could then pose a risk, as it has been well evidenced 
that geographical context shapes drug use (Galea, Ahern, & Vlahov, 2003; Nandi et al., 
2010), including factors of poverty and unemployment. Because drug markets in rural 
areas are predominately organized by close kinship and social networks, the diffusion of 
NMPO occurs at a greater rate than is does in urban regions (Keyes et al., 2014). Despite 
the limited economic capital in Appalachia Kentucky, there is evidence that indicates the 
use and diffusion of OxyContin has been significantly associated with increased social 
capital in rural areas (Jonas et al., 2012).  
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That is, distribution networks of NMPOs is integrating into the social fabric that 
has been established not by informal transactions in urban areas, but by individuals that 
often have close relationships, familial ties, or intimate relationships. These broad social 
networks with close personal ties that facilitate NMPO diffusion have been described as 
providing an increase in social capital in the community; ergo, an increase in status and 
power. It is then plausible to postulate that women may be more vulnerable in these 
transactions, especially if the distributor is an intimate partner, given the higher rates of 
IPV among rural women (Peek-Asa, Wallis, Harland, Beyer, Dickey, & Saftlas, 2011). 
As a result, rural systemic violence victimization may be described as a recursive pattern 
of IPV and self-medication, where the medication is provided by the perpetrator or a 
close acquaintance. This hypothesis is supported by the past research that found that 
female probationers who were NMPOs were significantly more likely than nonusers to 
have experienced IPV (Hall, Golder, Higgins, & Logan, 2016; Wu et al., 2010). 
Compared to the psychopharmacological and the economic-compulsive groups, 
this group had the fewest number of predicted participants (n = 55). This may be due to a 
lack of conceptual development in Goldstein’s (1985) conceptual framework around rural 
drug markets, and perhaps due to imprecise measurement operationalization in the 
current study due to the use of secondary data. These results are not entirely surprising 
given the nuanced differences between urban drug markets – in which the Goldstein’s 
(1985) framework was developed – and rural drug markets. Much of Goldstein’s (1985) 
systemic case for drug-related violence was predicated on territorial disputes, retribution 
for a variety of reasons (e.g., death of a gang member or selling low-quality drugs), and 
the elimination of confidential informants. Although there is some evidence of rural 
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gangs and gang members (Evans, Fitzgerald, Weigel, & Chvilicek, 1999; Swetnam & 
Pope, 2001), there is little support for widespread gang-related drug markets in rural 
areas such as Appalachian Kentucky. 
 Taken together, the findings relative to the systemic group may provide the 
greatest evidence for the incongruence between Goldstein’s (1985) conceptual 
framework as it is defined, and how it is portrayed in the lives of rural women. Rural 
drug-market systems do appear to function in a similar fashion to urban drug-market 
systems in that the distributors possesses a fundamental power differential to the 
recipient. However, the nature of these interactions potentially poses contrasts in that 
urban drug-market systems are largely managed by gangs, whereas rural drug-market 
systems are predominantly interwoven into kinship and social relationships in the 
community. In other words, rural drug-markets may be aptly described as less centralized 
than drug-markets that are dominated by gangs and gang violence. This rural drug-market 
configuration then may offer a new perspective of systemic violence, one that is not 
centralized by gang violence and turf wars, but by violence that occurs within the context 
of known personal/intimate relationships – of which justice-involved women are 
particularly vulnerable (Hall et al., 2016; Oser et al., 2009).  
This may indicate that rural drug markets are not necessarily fringe sectors of the 
community controlled by large organizations (e.g., gangs), but rather interwoven not only 
into the community but also within familial and social networks that are both formal and 
informal. And for women, this may mean navigating complex personal and intimate 
relationships that transcend the traditional, and often superficial relationships within an 
urban drug market; although, this study failed to determine the validity of such a claim. 
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Future research should continue to explore the systemic nature of rural drug markets and 
how their dyadic properties might place justice-involved women at a risk for violent 
victimization. 
Findings among Mental Health and Infectious Disease Factors 
 Mental disorders and infectious diseases are more common in justice-involved 
individuals than they are among the general population (Fazel & Baillageon, 2011). 
These high rates of behavioral health concerns may by connected to the nature of their 
lives, which for many included violence, substance use, and high-risk sexual activity. 
These issues are compounded for many justice-involved women in Appalachian jails, as 
drug use is prevalent and IDU is the preferred route of administration, service availability 
is limited, and there is evidence to suggest women in this region are apathetic to the 
health risks associated with IDU (Staton-Tindall et al., 2015b). Outside of the substantial 
health-risks associated with IDU, the social aspects of power and control that are related 
to IDU place many women in a position of greater vulnerability. Compared to men who 
inject drugs, women are more likely to introduced to IDU by an intimate partner, a dealer, 
or another family member (Tompkins, Sheard, Wright, Jones, & Howes, 2006).  
 Many individuals with mental illness cycle through jails on a continual basis. 
Estimates reveal that individuals with severe mental illness are admitted to jails at about 
8-times the rates that they are admitted to psychiatric centers (Ditton, 1999). Evidence 
indicates that jail-based women have greater prevalence of severe mental illness and 
significantly greater rates for major depression (Sacks, 2004). In addition, women who 
are detained in jails have high rates of co-occurring substance use and mental illness 
(Sacks, 2004). In addition, several studies have indicated the relationships between drug 
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use and IPV, and the intersecting factors of depression, PTSD, and intimate partners’ 
drug use (Rivera, Phillips, Warshaw, & Lyon, 2015). This study has attempted to move 
this literature forward by investigating how behavioral health risk factors may be 
associated with specific drugs/violence relationships. 
Mental Health Symptomology 
 Among justice-involved women, several studies have evidenced high rates of 
mental health problems (Sacks, 2004). Findings from the current study indicate that rates 
of mental health problems are relatively high compared to other samples. Specifically, 
about 61% of women in this sample reported symptoms of major depression, which is 
higher than in other studies of justice-involved women (15-25%) (Teplin, Abram, & 
McClelland, 1997). Rates for reported anxiety symptoms were also high among the 
current sample at approximately 59%, as ther studies have reported anxiety levels at 
around 18.5% (Binswanger, Merrill, Krueger, White, Booth, & Elmore, 2010). In 
addition, prevalence for symptoms of psychotic illness were notably higher in the current 
sample at nearly 22%, compared to 3.9% nationally (Fazel, Hayes, Bartellas. Clerici, & 
Trestman, 2016). However, prevalence of suicidal ideation was lower at about 10% 
compared to other jail-based estimates, which indicated prevalence at approximately 16% 
(Schaefer, Esposito-Smythers, & Tangney, 2016).  
 The binary logistic regression analyses produced several statistically significant 
associations between mental health symptomology and the psychopharmacological and 
economic-compulsive violence. The findings indicated that endorsement of symptoms of 
depression and of psychosis were both significantly associated with increased odds of 
psychopharmacological violence and economic-compulsive violence. In addition, 
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suicidal ideation was significantly associated with an increased odds of economic-
compulsive violence.  
 The findings relevant to depression and psychotic symptomology are consistent 
with past research involving justice-involved women (Staton-Tindall et al., 2015b). 
Evidence also suggests that IPV, drug use, and mental health conditions are 
interconnected and complex (Connelly, Hazen, Baker-Ericzen, Landsverk, & Horwitz, 
2013; Golder, Connell, & Sullivan, 2012; Jaquier, Flanagan, & Sullivan, 2015; Peters, 
Khondkaryan, & Sullivan, 2012). There is also evidence that indicates that depression 
may have a mediating effect on the relationship between substance use and IPV. For 
instance, among a nationally representative sample of women, it was discovered that 
women who had experienced IPV and depressive symptoms were more likely to have 
more severe substance use (La Flair, Bradshaw, Storr, Green, Alvanzo, Crum, 2012). 
Another study found that women who reported moderate to severe depressive symptoms 
were about 8-times more likely to report both violent victimization and substance-related 
problems (Paranjape, Heron, Thompson, Bethea, Wallace, & Kaslow, 2007).  
 Taken together, the current findings and past research suggest that drug use, 
violence victimization, and depression may have cumulative effects. Women in the 
current sample were predicted in the psychopharmacological due to the likelihood that 
their experience of drug-related violence was best explained by the effects of the drugs on 
the consumer (Goldstein, 1985). For example, participants may have used drugs to 
mitigate their mental health distress related to depression and psychosis; although, drug 
use has been found to longitudinally intensify mental health issues (Sullivan & Holt, 
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2008), and according to the psychopharmacological group, also increase their risk of 
violent victimization (Goldstein, 1985; 2003).  
 The rate of psychosis symptomology (22.3%) was notably higher in the current 
sample compared to many nationally (Lamb & Weinberger, 1998) and internationally 
(Fazel & Seewald, 2012) prevalence rates. Not only was prevalence for psychosis 
symptomology higher in the current sample, but it was the strongest mental health 
association, as it increased the odds of psychopharmacological violence by 2.48 times. A 
recent systematic review found that criminal victimization of persons with severe mental 
illness ranged from 2.3 to 140 times higher than reported in the general population 
(Maniglio, 2009; Swartz & Bhattacharya, 2017).  
This prevalence may be partially explained by the limited provider resources 
available to individuals with psychotic illness in Kentucky’s Appalachian region, who 
may in-turn be placed in county jails (Moody, Satterwhite, & Bickel, 2017). That is, in 
Appalachia Kentucky accessing treatment is difficult for many, and especially so for 
those with severe mental illness concerns. Mental health treatment access in rural 
Kentucky is often prohibited by travel distances with sparse public transportation 
resources, costs for the uninsured, and simply fewer specialized mental health providers 
(Moody et al., 2017). In addition, as demonstrated in the current study and others, women 
with psychotic symptomology often have low social functioning, have difficulties 
consistently securing housing and employment, and have comorbid SUD that increase the 
risk of victimization (Fazel, Långström, Hjern, Grann, & Lichtenstein, 2009; Latalova, 
Kamaradova, & Prasko, 2014).  
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To date, this study is the first to examine the association between suicidal ideation 
with Goldstein’s (1985) conceptual framework. Those in the economic-compulsive group 
were significantly associated with about a 1.5 greater odds of reporting suicidal ideation. 
Among jail inmates, suicidal ideation often precedes suicidal behavior and has been 
strongly correlated with completed suicide (Schaefer et al., 2016). From a 
sociodemographic perspective, white female jail inmates have been found to report 
suicidal ideation and attempt suicide at higher rates than black and male inmates 
(Charles, Abram, Mcclalland, & Teplin, 2003; Schaefer et al., 2016).  
Importantly, the current results should be contextualized within the economic-
compulsive group of drug-related violence. It may be that a greater dissatisfaction with 
life emerges from the conditions of working in an illegal economy in which sex is 
exchanged for drugs and money, and coercion and victimization is common. There is 
evidence to support this claim, as female sex workers who experienced sexual coercion 
and had issues related to substance use were more likely to report suicidal ideation 
(Hong, Li, Fang, & Zhao, 2006; Ling, Wong, Holroyd, & Gray, 2007).  However, 
much of this research has been conducted outside of the U.S. and is difficult to generalize 
to a unique rural subpopulation, such as justice-involved women in Appalachia 
Kentucky. There is less evidence to point to women who sell drugs for profit and an 
association to suicidal ideation; therefore, perhaps this finding is better explained from 
the economic conditions the drive these behaviors, and not the behaviors in-and-of-
themselves.  
The distressed economic conditions that span nearly all the Appalachian 
Kentucky region may be a key factor in the association between suicidal ideation and 
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economic-compulsive violence. Previous studies that deployed interview and survey data 
from diverse cohorts have found financial distress as a contributing factor to suicidal 
ideation and behavior (Duberstein, Conwell, Conner, Eberly, & Caine, 2004; Gertner, 
Rotter, & Shafer, 2019; Hempstead, & Phillips, 2015; Zhang, Conwell, Zhou, & Jiang, 
2004). A recent study found that marginal (i.e., ~$1.00) increases in state’s minimum 
wage policy was associated with a 1.9% decrease in annual suicide rates (Gertner et al., 
2019). Advancements in economic policy and furthering economic development for 
justice-involved women may be a critical step in improving the mental health concerns 
among the current sample. 
Although, long-term improvements to the financial security and the Appalachian 
labor markets – both of which have deteriorated over the past few generations – will be 
needed to sustain suicide ideation and other mental health and drug use concerns (Case & 
Deaton, 2017). Improving behavioral health treatment resources that are accessible is 
critical to curbing the mental health concerns previously mentioned. Justice-involved 
women with comorbid disorders are significantly more likely to have multiple problems 
in terms of employment, family relations, and health. In addition, they are at greater risk 
for unsuccessful treatment, recidivism, homelessness, violence victimization, and suicidal 
ideation/behavior when compared to those without this combination of disorders 
(Schaefer et al., 2016).  
From a clinical perspective, evidence suggests that screening instruments in jail 
settings is an effective method of identifying high-risk individuals, employing safety 
planning, and coordinating appropriate care to mitigate the risk of escalating suicidal 
ideation or behavior. However, identifying those at the greatest risk is difficult, and the 
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current screening instruments and clinical contacts may not fully capture individual risk 
factors (Hayes, 2010). Therefore, continued research is needed to better identify those at 
risk for suicide among jail-based populations. Since suicidal ideation is strongly 
associated with, and often precedes suicidal behavior, this study explored how suicidal 
ideation might be associated with constructs of drug-related violence. 
Those who are white, female, and who report violence victimization in 
association to their role in illegal drug markets and sex work may be at the greatest risk. 
Given the novel findings offered by the current study, and their potential for clinical 
implications, the generalizability of these results should be placed within a specific 
context. That is, the measurement of suicidal ideation in this study could not contain the 
nature of the suicidal thoughts. And, measures for the frequency and intensity of suicidal 
thinking were not captured. Finally, the current sample is unique to many of jail 
populations in that they were predominately white and rural, and generalizing clinical 
implications should only be considered in these contexts.  
Risk Factors for Infectious Disease 
The results of the current sample are in some ways congruent with the existing 
literature base. This study found that several significant associations between risk factors 
for infectious disease and each of the drugs/violence groups. As compared to the other 
predicted theoretical groups, the greatest number of associations of infectious disease risk 
factors was found with the psychopharmacological group. The most robust association 
was having a boyfriend/male partner introduce IDU to the participant. Among the 
participants who were introduced to IDU by a boyfriend/male partner, their odds of 
experiencing psychopharmacological violence were approximately 9-times greater than 
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for those who were not introduced in IDU in such a manner. This finding indicates that 
there may be a strong connection between social and structural violence, power relations 
within intimate relationships, and how these elements shape rural justice-served women’s 
risk environment.  
The role of violence, specifically violence perpetrated by an intimate partner, has 
been found to be a factor that might increase the risk of infectious disease (e.g., HCV) 
(Bourgois, Prince, & Moss, 2004). Compared to men, women who inject drugs have been 
reliably shown to be at greater risk for sharing injection equipment (e.g., syringes, 
cotton), and to be more reliant on male injection partners for both drugs and injection 
equipment (Frajzyngier, Neaigus, Gyarmathy, Miller, & Friedman, 2007). In addition, 
numerous studies have found that women are more likely to be second to inject when 
women are injecting drugs with a male partner (Bennett, Vellmann, Barter, Bradbury, 
2000; Frajzyngier et al., 2007; Shaw, Shah, Jolly, & Wylie, 2007).  
The current findings suggest a positive, and strong association with injection 
partnerships and drug-related victimization. Furthermore, this study also found a positive 
association related to condom use and psychopharmacological violence. Participants were 
nearly twice more likely to forget to use a condom because of the affects of their drug 
use. These finds build on current literature that has investigated injection partnerships and 
sexual relationships, and on the theoretical understanding of Goldstein’s (1985) 
conceptual framework. As observed in the current sample, the increased odds of 
psychopharmacological violence due to injection initiation and a sexual relationship 
might be explained by resource dependence and power imbalances.  
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Participants who may have been dependent on their intimate partner for drugs or 
injection materials and may have also experienced restricted control over their own 
injecting behavior (Lazuardi et al., 2012; Morris et al., 2014). The formation of this type 
of high-risk dyad might be constructed based on coercive control and violence; however, 
feminist scholars (Nussbaum, 1995; Nussbaum, 1999) and researchers (Bourgois et al., 
2004; Harvey, Bird, Galavotti, Duncan, & Greenberg, 2002; Pulerwitz, Amaro, De Jong, 
Gortmaker, & Rudd, 2002) have noted that inertness and the denial of autonomy can be 
reinforced by traditional gender-roles. Therefore, the inertness (Nussbaum, 1995) of a 
participant may be compounded by the effects of drug use and violence, leading to a 
passive role in the injection process, but the origins of this passivity might be best 
described by cultural gender norms.  
It is important to note that this study was unable to directly evaluate if relationship 
power or cultural gender norms in shaping injecting practices. Further, although the 
initiation of IDU does place an individual at higher risk for infectious disease contraction 
and transmission (Van Handel et al., 2016), this study was unable to determine the 
sequencing of injection behavior or if contaminated syringes were used. However, the 
current data did demonstrate that risk profiles differ in terms of the drugs/violence 
relationship, where the psychopharmacologic group showed unique risk in terms of 
injecting behavior for rural justice-involved women.  
Additionally, women in the current sample may have viewed their initiation to 
and continuation of IDU as a “reward” and “cost” dilemma (De et al., 2009; Hahn, 
Evans, Davidson, Lum, & Page, 2010; Morris et al., 2014). In this scenario, the “reward” 
is an increased closeness to her partner, extended trust within the relationship, and 
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mitigating of future violent events. The potential “cost” would then entail HCV 
transmission and a greater dependence on a male partner for drugs and injection 
equipment. The possible “costs” mentioned have been found to be more likely discarded 
within cohabitating sexual relationships (Rhodes & Quirk, 1999), which was evidenced 
in the current study when considering the findings related to condom use. 
The economic-compulsive group was also statistically significantly associated 
with an infectious disease risk factor. That is, each additional time a participant shared 
syringes, their increased risk of economic-compulsive violence nearly doubled. Victims’ 
of economic-compulsive violence are commonly individuals who reside in the same 
community as their perpetrator, and often the victims are engaged in illegal activity 
themselves (e.g., (Goldstein, 2003). Within this context, drug users and distributors as 
well as sex workers are common targets of economic-compulsive violence (Goldstein, 
2003).  
The current findings appear to align with the contemporary understanding of how 
macro- and micro-level environment factors impact economic autonomy, substance use, 
syringe access, gender-power imbalances, and violence. That is, a statistically significant 
factor in predicting the economic-compulsive group included sex work in exchange for 
drugs and money. In general, sex work is framed within a patriarchal hierarchy, by way 
of gender-power imbalances, gender-based violence, and by policy measures that favor 
punitive measures that are linked to increased risk for infectious disease (Shannon et al., 
2015).  
Relative to the economic-compulsive group, distressed economic conditions 
undergird many women’s entry into sex work and the risk conditions associated with 
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sharing syringes (Reed, Gupta, Biradavolu, Devireddy, & Blankenship, 2010). In other 
words, an economic vulnerability diminished participants’ negotiating power, which 
resulted in statistically significant greater risk for unprotected sex and sharing syringes – 
both of which investigated in this study and both are risk factors for HCV (Lelutiu-
Weinberger et al., 2009).  
Limited negotiating leverage and the desire to mitigate drug withdrawal 
symptoms may mean that participants’ most viable capital option was sex work. And, as 
mentioned, the gender-based inequalities that marked these exchanges may have also 
required that women were not first to inject and were subjected to use contaminated 
syringes. In addition, it is important to note the economic burden of dual roles (e.g., 
financially support children or other family members) that were faced by participants 
who were mothers, which was most of the sample. 
These factors mediate HCV vulnerability by reducing participants access to 
condoms, sterile injection equipment, and HCV prevention and treatment. Structural 
intervention strategies that modify the physical risk environment, which may reduce 
participants’ vulnerability to HCV infection, such as the provision of childcare at harm 
reduction programs and gender-specific – perhaps women-only – drug treatment 
programs (Rhodes & Treloar, 2008). Therefore, programs aimed at economic 
development in Kentucky’s Appalachian region ought to consider how gender-based 
economic inequalities intersect with women’s social- and health-based issues.  
Among a community-based sample in Appalachian Kentucky, syringe sharing 
was estimated at 10.5% for receptive sharing and 26.3% for distributive sharing (Havens, 
Walker, & Leukefeld, 2007). A subsequent study reported prevalence of 16.7% for 
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receptive and distributive sharing combined (Young, Jonas, Mullins, Halgin, & Havens, 
2013). Another study estimated receptive syringe sharing was higher among HCV-
positive participants (30.2%) compared to HCV-negative participants (15.2%) (Havens, 
Lofwall, Frost, Oser, Leukefeld, & Crosby, 2013). This region continues to be at high-
risk for HCV/HIV rapid outbreak (Van Handel et al., 2016), and rural justice-involved 
women, such as those included in this study, may be particularly vulnerable to this 
potential outbreak.  
Since 2015, Kentucky legislature has progressed from considering syringe service 
programs (SSP) illegal, to having approximately twenty-five operational SSPs (Bixler et 
al., 2018). Although the level of implementation, accessibility, and public support are 
mixed, Kentucky has considerably expanded its SSPs, where by 2017 it is estimated that 
31 counties and 8,078 persons had operational SSPs (two offering mobile services) 
(Bixler et al., 2018). Among the 54 Kentucky counties that were vulnerable to rapid 
HIV/HCV outbreak (Van Handel et al., 2016) – many of which are in Appalachia – 39% 
had SSPs in operation (Bixler et al., 2018). Nearly all (83%) of Kentucky’s SSPs offer 
infectious disease (i.e., HIV; HCV; STI) screenings, and all offer linkages to treatment 
services.  
These are promising steps forward; however, critical services for rural justice-
involved women are underdeveloped. For instance, family planning (58%), pregnancy 
testing (63%), and prenatal services (83%) are not comprehensively offered (Bixler et al., 
2018), which may be especially critical as Kentucky and other states substantially 
criminalize women’s reproductive rights. In addition, only 25% of SSPs offer housing 
assistance, transportation services, food assistance, while 42% offer health insurance 
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enrollment (Bixler et al., 2018). If these programs continue to evolve and are funded 
appropriately, Kentucky’s lawmakers should consider the unique needs of their justice-
involved women, as there is an opportunity for the expansion of these programs that 
integrate the health, social, and economic needs of justice-involved women.  
Recommendations for Substance Use Disorder Treatment Providers 
 It is imperative to recognize that most women do recover from abuse and prove 
extraordinary resilience in the face of substantial barriers related to enduring violent 
victimization. In addition,, most women who use drugs do so without developing a SUD, 
and among those who do, many have not been a victim of violence. Survivors may 
pursue professional aid to address substance use problems that interfere with daily life or 
contribute to mental or physical health concerns. Evidence has indicated there are 
trauma-specific interventions that are effective in addressing a range of trauma-related 
mental health and co-occurring conditions (Dass-Brailsford & Myrick, 2010; Fowler & 
Faulkner, 2011; Macy & Goodbourn, 2012). Without addressing the specific needs of 
survivors who are also dealing with an abusive partner, SUD treatment may not be 
accessible or effective or may even place survivors at greater risk for harm. 
 These interconnecting issues are best addressed through care that is coordinated 
and implemented in a manner that is responsive to gender-specific perspective (Bennett 
& O'Brien, 2010; Schumacher & Holt, 2012). Considering Appalachian Kentucky, 
gender-responsive peer supports should ideally be familiar with the cultural norms and 
the needs of women that are unique to the region. Currently, there are two gender-
responsive trauma-informed SUD treatment programs that have been rigorously assessed 
that offer effectiveness: Women’s Integrated Treatment (Covington, Burke, Keaton, & 
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Norcott, 2008) and Seeking Safety (Najavits, 2007). Yet, studies on the effectiveness of 
alterations for justice-involved women are still needed. A recent systematic review of 
trauma-focused interventions for IPV survivors (Warshaw, Sullivan & Rivera, 2013) 
identified only one that was developed specifically for survivors dealing with a substance 
use disorder: The Relapse Prevention and Relationship Safety (Gilbert et al., 2006) 
(RPRS) exhibited potential in addressing women’s substance abuse and violent 
victimization (Gilbert et al., 2006). 
 Moreover, challenges related to treatment engagement and attendance may 
present if participants are experiencing ongoing victimization. This same point could also 
apply if violent victimization is occurring outside of an intimate relationship, where a 
chaotic and high-risk environment would pose barriers to treatment utilization (Victor et 
al., 2018). It is vital that SUD treatment providers understand that abusive partners often 
actively destabilize a survivor’s efforts toward recovery, by means of isolation from 
sources of support, and use a survivor’s dependence on substances as a way of coercive 
control. The implications of substance use coercion may extend to an individual’s ability 
to access economic support, employment, or social support. This is in addition to the 
stigma that many people experience regarding substance use, as well as trauma-related 
feelings that may emerge as a result of being victimized and controlled (Warshaw & 
Brashler, 2009).  
Treatment Issues Specific to Jails 
 Most jurisdictions have drug treatment courts in place to divert offenders prior to 
trial or be placed in following a conviction (Marlowe, 2003). Following the sentence, jail-
based treatment interventions should be explored, as they are available and there is 
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evidence of promising outcomes (Lutgen, 2018). In addition, pre-trail options related to 
jail diversion should be strongly considered as should linkages to reentry services should 
the individual serve a period of incarceration. For vulnerable women with complex 
histories of drug use and violence victimization several options should be explored by 
correctional facilities. These options may include residential treatment, outpatient and 
intensive outpatient treatment, medication-assisted treatment, and therapeutic 
communities (TC) (Belenko, Hiller, & Hamilton, 2013). Therapeutic communities offer 
peer-led recovery that can be summarized as social, emotional, and practical support from 
individuals with a shared history (Andreas, Ja, & Wilson, 2010; Solomon, 2004). 
In studies that investigated TCs effectiveness compared to control conditions 
(e.g., case management, traditional outpatient substance use treatment, substance use 
education, traditional mental health treatment) there was variation in effectiveness. 
Compared to traditional treatments, there is evidence that TCs have had similar and 
significantly better substance use outcomes (Greenwood, Woods, Guydish, & Bein, 
2001) criminal justice involvement outcomes (Welsh, 2007), employment outcomes 
(French, Sacks, De Leon, Staines, & McKendrick, 1999) and mental health outcomes 
(French et al., 1999; Leon, Sacks, Staines, McKendrick, 2000).  
Therapeutic communities services may offer a different option for state 
correctional systems and the courts, and for those clients who fail to connect with formal 
outpatient, intensive outpatient, or short-term residential treatment. Further, by being free 
from treatment facility licensure, accreditation standards, and medical-model treatment 
approaches, the recovery model is potentially far less costly than traditional treatment50. 
Vulnerable populations in medically underserved areas, such as the current sample, may 
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find TCs as an increasingly resourceful option amidst rising substance-related problems 
and declining resources to deal with the problem. 
 Compared to prisons, jails have frequent turnover and shorter average stays 
making them a significant potential intervention point for treatment. Therefore, some of 
the most viable jail-based treatment options are Screening, Brief Intervention, and 
Referral to Treatment (SBIRT) interventions (Chandler, Fletcher, Volkow, 2009). Many 
of SBIRTs incorporate the Transtheoretical Model of Change and Motivational 
Interviewing (MI). These interventions are effective because they are adaptive to the 
needs of the clients, they enhance communication and engagement, and they provide a 
low-demand way to explore the major experiences that require clincal focus, and because 
they provide ways to navigate client’s ambivalence (Miller & Rollnick, 2009; Wahab, 
2006). 
Evidence from recent studies indicate that there are promising SBIRT models for 
justice-involved women. For instance, the Jail In-Reach Intervention uses evidence-based 
screening instruments to identify individuals with severe SUD (Begun, Rose, LeBel, 
2011). Begun and colleagues (2011) recently tested the effectiveness of the Jail In-Reach 
Intervention using a randomized controlled trial (RTC) research design with a sample of 
incarcerated women. The intervention group included MI with feedback on participant’s 
drug use, and a timeline follow-back interview. The control group received the standard 
jail protocol, which included a resource folder with information on the available 
community-based treatment. At the 12-month follow-up, the intervention group reported 
significantly lower drug and alcohol use; yet, regardless of study condition, participants 
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who used the community folder were three times more likely to utilize community-based 
treatment (Begun et al., 2011).  
 The aforementioned study is one of many that has indicated that linking jail 
inmates to treatment at community reentry is vital to improving post-release outcomes 
(Oser et al., 2009; Peyton, 2001; Staton-Tindall et al., 2011a; Staton-Tindall, Duvall, 
McNees, Walker, & Leukefeld, 2011). Providing a continuum of care for justice-involved 
individuals is a key element to reducing substance use and engaging in substance use 
treatment. In addition, given the linkages found in the study between drug use and 
violence victimization, reductions in substance use could aid in also reducing outcomes 
related to violence.  
Considering economic-compulsive and systemic violence, drug treatment 
interventions may also reduce the threat of victimization by improving employability, 
stabilizing familial and social supports, and mitigating the involvement in high-risk 
situations (e.g., sex work). In turn, many of these improved outcomes have also been 
found to reducing recidivism, by addressing the root causes that significantly propel the 
cyclical nature of arrest and incarceration (Staton-Tindall et al., 2011a). 
 Many interventions have shown effective outcomes and have been increasingly 
accepted by correctional- and policy-based decision-makers. Among the most effective 
interventions for jail-based drug treatment – especially the treatment of opioids – is 
medication-assisted therapy (MAT). This is an evidence-based practice for jail-based 
drug treatment with highly efficacious and effective outcomes (Amato, Davoli, Perucci, 
Ferri, Faggiano, & Mattick, 2005; Egli, Pina, Skovbo-Christensen, & Aebi, 2009; 
89 
 
Westerberg, McCrady, Owens, & Guerin, 2016; Lee et al., 2012) and with costs 
comparable with traditional treatments (Horn, Mamun, McCrady, French, 2018).  
For instance, a clinical trial data show MAT that is initiated during jail 
incarceration can improve community-based MAT utilization and outcomes for opioid-
dependent individuals (Magura, Lee, Hershberger, Joseph, Marsch, Shropshire, & 
Rosenblum, 2009). Magura and colleagues (2009) randomly assigned opioid-dependent 
individuals to either buprenorphine or methadone. The buprenorphine group was 
significantly to continue MAT in the community upon reentry, but at the 3-month follow-
up both groups were similar in terms of their self-reported criminal-involvement and 
substance use. In the same study, the methadone group appeared to be dose-responsive, 
as those who had higher doses in jail had significant increases in seeking treatment at 
reentry (Magura et al., 2009).  
 Another study using justice-involved Appalachian women has examined how 
both the licit and illicit patterns of buprenorphine use post-release from jail, and how this 
use correlated with contacts with health services and recidivism (Surratt, Staton, 
Leukefeld, Oser, & Webster, 2018). This study found that only 5.2% of the sample had 
received buprenorphine uptake through medical channels and 23.0% reported diverted 
buprenorphine use (Surratt et a., 2018). There were no reported re-arrests among those 
who reported licit buprenorphine use. However, drug use frequency and severity, 
including illicit buprenorphine use, were independently associated with re-arrest at the 3-
month follow-up period. In addition, the strongest indicator of avoiding re-arrest was 
having a regular source of health care.  
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The authors note that a continuum of care from a health care professional(s) 
provides a therapeutic benefit for behavioral health issues, pain, and other physical health 
concerns for justice-involved Appalachian women (Surratt et al., 2018). It is difficult to 
neglect the promising evidence for MAT services for an underserved population in 
Appalachia, in accordance with consistent health care available, but it is not entirely clear 
whether health care access improves access to MAT. Nonetheless, these findings point to 
the underdevelopment of MAT interventions in rural areas, whilst also providing 
evidence of MAT’s effectiveness in curbing re-arrest and substance use for a unique 
population group. Although the relationship between MAT and violence was not directly 
examined in the current study, it may be plausible to reason that greater MAT access 
through formal channels could mitigate threats of drug-related violence for the current 
sample.  
Increasing access to rural justice-involved Appalachian women may require a 
greater integration of MAT into a suite of health care settings, including rural health 
centers, primary care, and federally qualified health centers (Surratt et al., 2018). This 
expansion of MAT may prove difficult, as many correctional staff and policymakers 
harbor negative views of this treatment on the grounds that users are substituting one 
addiction for another (Friedmann et al., 2012; McMillan & Lapham, 2005).  
Nearly 83% of jails provide some type of MAT, yet much of the time access is 
limited to specialized needs such as detoxification for pregnant women or for those 
already on methadone maintenance at the time of arrest. Compared to jail settings, drug 
courts (37.5%) and probation and parole agencies (17.0%) lag further behind in their 
MAT implementation (Friedmann et al., 2012). Moreover, nearly half of all drug courts 
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of policies that forbid the use of this evidence-based practice (Matusow et al., 2013). The 
resistance to MAT stems from several concerns; including, local regulations, inadequate 
funding, diversion concerns, and institutional philosophy that is grounded on abstinence-
based treatment (Matusow et al., 2013).  
The delivery of effective drug treatment to justice-involved Appalachian women 
can be considerably more challenging than in typical community settings. Efforts in 
research have established consensus and a set of principles for providing effective 
treatment for justice-involved persons (Chandler et al, 2009). These principles integrate 
the unique characteristics of the justice-involved populations that can critically 
complicate effective treatment. These include high rates of psychological conditions, 
cognitive deficits, risk-taking, and criminal thinking patterns and moral competencies.  
For justice-involved Appalachian women, the risk–needs–responsivity (RNR) 
principle has been shown to be more effective and it may provide a useful therapeutic 
tool (Smith, Gendreau, & Swartz, 2009). Included in the RNR framework, evidence-
based principles for effective treatment should incorporate 1) comprehensive actuarial 
assessment of static and dynamic risk factors with periodic reassessment; 2) prioritizing 
treatment resources for higher-risk offenders; 3) targeting interventions for criminogenic 
needs, such as criminal thinking and errors in judgment; and 4) provide treatment that is 
responsive to Appalachian women’s temperament, learning style, motivation, culture, and 
gender-specific needs (Taxman & Belenko, 2011). 
In addition to the principles outlined above, NIDA has developed a set of 
treatment principles as they apply to criminal justice populations. This set of principles 
ostensibly amounts to a reflection of what addiction science experts point to as evidence-
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based practices and principles (NIDA, 2006). In concert with the principles noted above, 
NIDA recommends that treatment for justice-involved populations should include: 1) be 
of sufficient length, especially for those with co-occurring mental health disorders and 
other social and health problems, such as the current sample; 2) increase motivation and 
build skills for resisting drug use and criminal behavior; 3) include on-going monitoring 
through urine testing, and use of structured rewards and sanctions to manage behavior; 4) 
involve collaboration and communication between treatment clinicians and CJS staff to 
monitor client progress; 5) provide continuity of care as offenders move through the CJS 
and back to the community; 6) integrate treatment for offenders with co-occurring mental 
health disorders; and 7) use MAT where clinically appropriate, with careful attention to 
monitoring adherence.  
The continued expansion and implementation of these guidelines should continue 
in rural Appalachia given the documented needs of an underserved and vulnerable 
population with complex needs. Although many of the treatment guidelines have 
evidenced effectiveness in curbing substance use and criminal behaviors, they do not 
directly address the risk for drug-related violence. Engagement in effective and culturally 
competent treatment may in theory reduce the risk of drug-related violence, but there 
must also be consideration as to how past and current victimization may interfere with the 
treatment process. Therefore, it is important to highlight the importance of screening for 
psychological distress, trauma symptoms and drug-related violence among justice-
involved Appalachian women.  
A recent systematic review recognized five evidence-supported screening tools 
for psychological distress among justice-involved individuals (Martin, Colman, Simpson, 
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& McKenzie, 2013). Screening, for psychological distress among women involved in the 
criminal justice system may improve the overall health of women, make for a more 
successful return to the community, and reduce recidivism. Additionally, given the 
evidence that SUD is greater among justice-involved women compared to men (Fazel & 
Hayes, 2017), and the unique risks for drug-related victimization and health risk-factors, 
it is critical that rural criminal justice systems incorporate gender-specialized screened, 
and addiction and general health services.  
Recommendations for Research 
 With the current study included, the existing body of research in this area has 
predominately focused on establishing statistical relationships between drug use and 
violence, and the direction(s) of this phenomena. Although recently there has been more 
research conducted on rural populations, much of this literature has focused on 
individuals in urban settings. Due to this geographical and cultural imbalance in study, 
there are still problems with the operationalization and measurement of terms, which can 
adversely affect the implications of the research. The following section will provide 
recommendations aimed at ways in which future research might be more valid, 
comprehensive, and reflective of the issues relevant to rural justice-involved women.  
 Future studies should aim to improve measurement of violence victimization, and 
make distinctions between IPV, that with which occurs within familial or intimate 
relationships, and community-based violence. The use of and further development of 
standardized measures for IPV is encouraged, as there are several instruments that have 
been found effective when used separately or in conjunction (Adams, Sullivan, Bybee, & 
Greeson, 2008; Beeble, Bybee, & Sullivan, 2007; Coker, Pope, Smith, Sanderson, & 
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Hussey, 2001). These instruments have been found to accurately measure the non-
physical aspects of IPV, such as coercion related to mental health and substance use.  
Having said that, there is still a great need to continue researching the 
phenomenology of rural drug-related violence for justice-involved women, as it related to 
measurement, typology, culture, and causal inferences. Although the current study has 
identified several novel findings related to drug-related violence, it is still unclear how 
these findings demarcate community-based victimization to IPV, and the applications of 
these findings to Goldstein’s (1985) conceptual framework are still underdeveloped. That 
is, the Goldstein (1985) is a useful research tool for conceptualization purposes, but its 
application and operationalizability may be limited by its scope (e.g., no control for 
traumatic childhood experiences), and its development concerning cultural (e.g., rural 
populations) and gender (e.g., perspective of victimization) idiosyncrasies. 
In addition, future research is needed to enhance the understanding of 
organizational and implementation science related to evidence-based treatment for rural 
justice-involved women (Taxman & Belenko, 2012). Implementation science is an 
emerging field that seeks to understand pertinent factors that facilitate successful and 
sustained application of evidence-based practice in various settings. Future research 
should aim to guide this line of research as rural jails and rural justice-involved women 
are concerned.  
Future research should also consider investigating the numerous linkage points 
along the sequential intercept map (Willison, McCoy, Vasquez-Noriega, Regional, 2018) 
and how to best integrate intervention for rural women along this continuum. Reducing 
gaps in treatment access is particularly important given the disjointed nature of the 
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criminal justice system and the numerous treatment needs of rural justice-involved 
women; including, limited and disparate service availability, and the issues of rurality 
(e.g., long travel distances and poor public transit). A further breakdown of the needs for 
future research are displayed in Figure 3. 
Topic Areas Specific Inquiries 
Jail-Based Treatment Research 
Outcomes of jail-based treatment 
 
Effectiveness comparisons between brief, short-term, 
and long-term interventions 
 
Predictors of treatment outcomes 
 
Implementation of aftercare 
 
Accessibility of MAT 
Structural & Social 
Determinants of Jail-Based 
Services 
Barriers to treatment (e.g., cost, stigma, power & 
control) 
 
Trust and community involvement 
 
Drug use coercion and access to law enforcement 
Measurement 
Primary data collection with the purpose of 
investigating drugs/violence nexus 
 
Improve data coordination between health and 
criminal justice professionals 
 
Temporal ordering of drug use and violent 
victimization 
Violence Victimization 
Increase attention to drug-related violence as it 
related to infectious diseases 
 
The role of antecedents such as trauma and structural 
violence on women’s use of drugs and criminality 
 
Emphasis on intimate injection partnerships, high-
risk injecting & victimization 
Population Factors 
Effects of dual roles (e.g., mother, wife, partner, 
caretaker) on parenting, drug use and criminal 
behavior 
 
Impacts of poverty and marginalization on drug use 
and criminality 
 
Women’s role within rural illicit drug markets 
Figure 3: Recommendations for research with rural justice-involved women. 
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Role of Social Workers 
 Social workers are well positioned to fulfill a robust role as interventionists and 
policy-makers on behalf of the vulnerable population group of justice-involved women. 
The results of the current study are reflective of one of the profession’s current Grand 
Challenges: The Smart Decarceration Initiative (SDI) (Herbert-Williams, 2016). To date, 
many of the SDI recommendations have been developed around policy- and macro-level 
innovations (Epperson & Pettus-Davis, 2016). These recommendations aimed to build 
social capacity and reduce incarceration rates for vulnerable populations. Specifically, 
Epperson and Pettus-Davis (2016) four recommendations for the SDI were as follows: 1) 
use incarceration primarily for incapacitation of the most dangerous; 2) make reduction 
of disparities a key outcome in decarceration efforts; 3) remove civil and legal 
exclusions; and 4) reallocate resources to community-based supports. Regarding rural 
justice-involved women, social workers that are framing policy and community-based 
interventions should target reductions in outcomes related to economic and behavioral-
health disparities (including violent victimization). 
Social workers can also facilitate evidence-based practices for individual-level 
interventions for justice-involved women. As licensed practitioners, social workers are 
vital to the treatment of SUD approaches; such as, reentry services, outpatient, intensive 
outpatient, inpatient, residential, and jail-based brief interventions (Kouyoumdjian et al., 
2015; Riekmann, Kovas, Cassidy, & McCarty, 2011). Social work also has a long history 
in issues related to child welfare services. Most children with incarcerated mothers have 
elevated levels of behavioral health issues and greater disruption given the experience of 
multiple placements (Seymour, 2017).  
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Social workers must continue to meet the clinical and social needs of these 
children and their mothers, provide care that encourages reunification, and advocate 
against the termination of parental rights due to issues related to SUD. The issues that are 
relevant to child welfare concerns and justice-involved women stem from a mother’s 
removal from society. To that end, diverting offenders from incarceration and toward 
community services could also alleviate Kentucky’s overburdened child welfare and 
criminal justice systems.  
In Kentucky, an effective and cost-effective tool for diverting individuals from the 
criminal justice system to treatment systems is the Alternative Sentencing Worker 
Program (ASWP). Following arrest, a defendant might receive a screening, brief 
intervention and referral to treatment (Babor, McRee, Kassebaum, Grimaldi, Ahmed, & 
Bray, 2007), or be diverted to community treatment under pretrial supervision conditions 
(Belenko, 1999) as an alternative sentencing (Farabee & Leukefeld, 2001). Unlike many 
uniform referral services that are provided to justice-involved populations, the ASWP 
works directly with clients to develop a plan that meets the client’s needs and introduces 
this report for the Court’s approval.  
Alternative Sentencing workers also work closely with Kentucky communities to 
forge working relationships to enhance cooperation with Court officials, and to best 
allocate the appropriate resources to clients. As of 2016, all eight of Kentucky’s 
Alternative Sentencing workers held master’s degrees in social work. In addition, the 
ASWP integrates Motivational Interviewing techniques to facilitate client’s change 
processes and their participation in the program. Motivational Interviewing is an 
evidence-based practice that has strong evidence of support for the services offered by 
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the ASWP and within criminal justice settings more generally (Carroll et al., 2006; Miller 
& Rollnick, 2002; Vader, Walters, Prabhu, Houck, & Field, 2010). 
Limitations 
 Several limitations must be mentioned. This was a cross-sectional study that 
examined correlational effects; therefore, it was unable to determine causation. This 
study utilized an analysis of extant data, so the use of proxy measures was used as a 
necessity, and the definition of variables was not as precise as it may have been with a 
primary data source. Due to this limitation, unexplained variance may exist that was not 
captured by the selected variables. Future research should incorporate multiple data 
sources (e.g., correctional intake date; public health data; police records) to operationalize 
variables specific to the drugs/violence nexus and to establish temporal ordering. In 
addition, although efforts were located measurements that encompassed similar 
timeframes, temporal ordering of drugs/violence events remained unknown.  
For instance, it is unclear if acute drug use directly preceded violent victimization, 
nor was it clear how traumatic antecedents in childhood and adolescents may have 
contributed to substance use later in life, and thus, to victimization in adulthood. 
Additionally, this study makes many conceptual references to gender as a term that 
identifies the relative needs of individuals who are biologically female. It is unclear 
whether any of the women in this study identify as a gender outside of the one they were 
designated at birth, and in many cases the use of gender could be more accurately 
described as sex. The use of gender in this context was applied so it would be consistent 
with the references made to the works in the humanities and to evidence-based treatments 
that identify as “gender-responsive.” Although this study was the first to examine the 
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drugs/violence nexus exclusively among rural justice-involved women, the current 
findings limited potential generalizations beyond the current sample or drug-involved 
rural justice-involved women. 
Conclusions 
 Among rural justice-involved women, drugs and violent victimization were 
shown to be significantly connected in three possible ways (i.e., 
psychopharmacologically, economic-compulsively, and systemically). The discriminant 
function analyses indicated that these relationships had varied prevalence, as the 
psychopharmacological group was the most supported, followed by economic-
compulsive group, and the systemic group, respectively. These different forms of drug-
related violent victimization were shown to be substantiated by numerous classes of 
drugs, different structural and economic contexts, and different social contexts.  
Given these findings, the phenomena of drug-related violence victimization 
among rural women was mixed in its congruence with the original formulation of the 
drugs/violence nexus (Goldstein 1985; 2003). For instance, the psychopharmacological 
was highly prevalent and the use of methamphetamine contributed significantly to 
experience of violent victimization. Yet, most drug classes that predicted membership in 
the psychopharmacological group were sedative in nature, which contrasts to Goldstein’s 
(1985) conceptualization that is heavily influenced by stimulant use. Further, economic-
compulsive factors, such as selling drugs and sex work in exchange for drugs and money, 
also significantly contributed to predicting membership in the economic-compulsive 
group. This study also found support for a conceptual basis of the systemic group, 
100 
 
although this group had the least number of predicated participants included in the model, 
and there was no statistical support for the systemic group in subsequent analyses.  
To the latter finding, this study also contributed noteworthy considerations for 
how the Goldstein (1985) conceptual framework may be adapted by a greater focus on 
victimization and the gender-specific experiences of rural women. For example, 
Goldstein (2003) noted that per his research in New York City, is that the area of 
systemic violence dominates much of the violence directed at drug users. This assertion is 
not supported from the perspective of the current study. The data suggests that the 
systemic group was the least influential among drug-using rural women.  
The systemic group the least prevalent per the discriminant function analyses it 
did not have any significant associations to the mental health factors nor the risk factors 
for infectious disease. Future research involving rural justice-involved women must 
evaluate drug-related violence on a spectrum based on how coercive control specifically 
relates to psychopharmacological and economic-compulsive violence, and to continue to 
explore ways to operationalize systemic violence in rural areas where gang involvement 
is limited, if not non-existent in certain areas.  
Following the construction of the three drugs/violence groups, this study was able 
to identify several significant mental health concerns and infectious disease risk factors 
that were associated with the psychopharmacological and economic-compulsive groups. 
The initiation of injection behavior was strongly associated with psychopharmacological 
violence. Risky sexual behavior and symptomology consistent with depression and 
psychosis were also significantly associated with psychopharmacological violence. More 
research is needed to better understand how these factors may be interrelated. Depression 
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and suicidal ideation were significantly associated with economic-compulsive violence 
which may highlight the complex intersection between economic distress, drug use, 
structural and interpersonal trauma, and power and control. The original Goldstein (1985) 
conceptual framework and subsequent reviews (Goldstein, 2003) are relatively silent on 
how these conceptual factors may map onto behavioral health concerns.  
To that end, this study has presented novel data that future studies can build upon 
in better understanding how specific drug-related violence situations might have unique 
behavioral health risks. Although this study is not conclusive, this research might be 
useful in developing screening and assessment instruments in crisis centers and 
correctional settings. For instance, there is now evidence that rural women who present 
with economic-compulsive violence histories may be more likely to report suicidal 
ideation, and that psychopharmacological violence histories may be indicative coercive 
injection behavior. Social workers and other practitioners, along with policymakers, must 
continue to develop coordinated and integrated interventions that are gender-responsive, 
trauma informed, culturally attuned to the needs of justice-involved rural women. Lastly, 
practitioners and researchers must deliberate factors outside the individual-level that will 
improve policy and practice and ultimately promote the decriminalization of drug use and 
the diversion of vulnerable women from jails to treatment centers and outpatient care. 
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Therapy; Comparative Criminology; Drug and Alcohol Dependence  
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Mitigation in Capital Cases 
2016 - 2017 
Law 813: Capital Punishment, University of Kentucky College of Law (audited) 
 
2015-Present 
Capital Trial Defense Team Case Reviews: Kentucky’ Department of Public Advocacy.  
 
Capital Defense 101: Department of Public Advocacy, Frankfort, Kentucky. April 2016-
Present.  
 
2013-2014 
University of Kentucky: Preparing Future Faculty 
 
2013 
KVC/Diversion and FPP Service Training 
 
2012 
KVC/Trauma Systems Training  
Motivational Interviewing Fidelity Training 
 
